JazzyTazzy的个人主页 - 老虎社区

JazzyTazzy

JazzyTazzy

暂无个人介绍

IP属地：未知

13关注

6粉丝

0主题

0勋章

2021-06-12

Let’s go

S&P ekes out gains to close languid week

2021-02-18

Yay!!!

Tesla reduces price of base variant of Model 3 and Model Y

2021-02-17

[财迷]

2021-02-16

[开心]

Not enough data yet about vaccine effect on COVID-19 spread- UK PM Johnson

2021-02-15

[微笑]

抱歉，原内容已删除

2021-02-14

Ok

Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO

2021-02-13

Wow

抱歉，原内容已删除

2021-02-12

Up up up

Here's the formula for spotting genuinely undervalued companies, claims this investment house

2021-02-12

好

FOREX-Bitcoin clings to Tesla gains, dollar set for weekly loss

2021-02-07

Ok

抱歉，原内容已删除

2021-02-07

Ok

抱歉，原内容已删除

2021-02-06

[呆住]

BUZZ-U.S. stocks weekly: Gaming more aid

2021-02-05

[微笑]

Too delicate: Germany ducks Taiwan appeal for COVID-19 vaccine supply

2021-02-04

Another big player

Apple may build a fully autonomous electric car with Hyundai-Kia: report

2021-02-04

Up

UPDATE 1-Social network Parler terminates CEO John Matze

2021-02-04

Good

Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen

2021-02-03

Nice

PRESS DIGEST- Financial Times - Feb. 3

2021-02-03

赞！

New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine

2021-02-02

[财迷]

'Black Panther' director developing Wakanda TV series for Disney+

2021-02-02

[开心]

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3567658644109643","uuid":"3567658644109643","gmtCreate":1604564621332,"gmtModify":1611922363691,"name":"JazzyTazzy","pinyin":"jazzytazzy","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":13,"tweetSize":21,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":188565115,"gmtCreate":1623455571137,"gmtModify":1634033057017,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Let’s go","listText":"Let’s go","text":"Let’s go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/188565115","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://www.laohu8.com/m/news/2142204074?lang=&edition=full","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","QQQ":"纳指100ETF",".DJI":"道琼斯","DOG":"道指反向ETF",".IXIC":"NASDAQ Composite","UPRO":"三倍做多标普500ETF",".SPX":"S&P 500 Index","UDOW":"道指三倍做多ETF-ProShares","OEX":"标普100","QID":"纳指两倍做空ETF","SH":"标普500反向ETF","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF","DJX":"1/100道琼斯","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","QLD":"纳指两倍做多ETF","DXD":"道指两倍做空ETF","PSQ":"纳指反向ETF","SDOW":"道指三倍做空ETF-ProShares","DDM":"道指两倍做多ETF","SDS":"两倍做空标普500ETF","TQQQ":"纳指三倍做多ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384166185,"gmtCreate":1613627254947,"gmtModify":1634552877842,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Yay!!!","listText":"Yay!!!","text":"Yay!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/384166185","repostId":"2112863205","repostType":2,"repost":{"id":"2112863205","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613625832,"share":"https://www.laohu8.com/m/news/2112863205?lang=&edition=full","pubTime":"2021-02-18 13:23","market":"us","language":"en","title":"Tesla reduces price of base variant of Model 3 and Model Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2112863205","media":"Reuters","summary":"Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.\n\n\nTesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.","content":"<p>Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.</p>\n<p>Tesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla reduces price of base variant of Model 3 and Model Y</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla reduces price of base variant of Model 3 and Model Y\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-18 13:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.</p>\n<p>Tesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2112863205","content_text":"Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.\nTesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.","news_type":1},"isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":385784843,"gmtCreate":1613576311482,"gmtModify":1634553075085,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[{"img":"https://static.tigerbbs.com/9faf84e9f534c3dfd62f018bc08dc86d","width":"1125","height":"3035"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/385784843","isVote":1,"tweetType":1,"viewCount":752,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":382821194,"gmtCreate":1613432028718,"gmtModify":1634553724337,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"[开心]&nbsp;","listText":"[开心]&nbsp;","text":"[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/382821194","repostId":"2111001462","repostType":2,"repost":{"id":"2111001462","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613408688,"share":"https://www.laohu8.com/m/news/2111001462?lang=&edition=full","pubTime":"2021-02-16 01:04","market":"us","language":"en","title":"Not enough data yet about vaccine effect on COVID-19 spread- UK PM Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2111001462","media":"Reuters","summary":"LONDON, Feb 15 (Reuters) - There is not yet enough data about how vaccines are affecting the spread ","content":"<html><body><p>LONDON, Feb 15 (Reuters) - There is not yet enough data about how vaccines are affecting the spread of COVID-19, British Prime Minister Boris Johnson said on Monday as he faces pressure from some of his own lawmakers who are keen to ease lockdown measures. </p><p>   \"Although the vaccination programme is going well, we still don't have enough data about the exact effectiveness of the vaccines in reducing the spread of infection,\" he told a news conference.</p><p> (Reporting by Guy Faulconbridge; writing by Costas Pitas; editing by William James)</p><p>((Costas.Pitas@thomsonreuters.com; 0207 513 4700; Reuters Messaging: costas.pitas.thomsonreuters@reuters.net and @Cpitas on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Not enough data yet about vaccine effect on COVID-19 spread- UK PM Johnson</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNot enough data yet about vaccine effect on COVID-19 spread- UK PM Johnson\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-16 01:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>LONDON, Feb 15 (Reuters) - There is not yet enough data about how vaccines are affecting the spread of COVID-19, British Prime Minister Boris Johnson said on Monday as he faces pressure from some of his own lawmakers who are keen to ease lockdown measures. </p><p>   \"Although the vaccination programme is going well, we still don't have enough data about the exact effectiveness of the vaccines in reducing the spread of infection,\" he told a news conference.</p><p> (Reporting by Guy Faulconbridge; writing by Costas Pitas; editing by William James)</p><p>((Costas.Pitas@thomsonreuters.com; 0207 513 4700; Reuters Messaging: costas.pitas.thomsonreuters@reuters.net and @Cpitas on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111001462","content_text":"LONDON, Feb 15 (Reuters) - There is not yet enough data about how vaccines are affecting the spread of COVID-19, British Prime Minister Boris Johnson said on Monday as he faces pressure from some of his own lawmakers who are keen to ease lockdown measures.    \"Although the vaccination programme is going well, we still don't have enough data about the exact effectiveness of the vaccines in reducing the spread of infection,\" he told a news conference. (Reporting by Guy Faulconbridge; writing by Costas Pitas; editing by William James)((Costas.Pitas@thomsonreuters.com; 0207 513 4700; Reuters Messaging: costas.pitas.thomsonreuters@reuters.net and @Cpitas on Twitter))","news_type":1},"isVote":1,"tweetType":1,"viewCount":786,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":382379432,"gmtCreate":1613373033226,"gmtModify":1634553820733,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/382379432","repostId":"2111005930","repostType":2,"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":386469204,"gmtCreate":1613258317708,"gmtModify":1634554099655,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386469204","repostId":"2111807728","repostType":2,"repost":{"id":"2111807728","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613256424,"share":"https://www.laohu8.com/m/news/2111807728?lang=&edition=full","pubTime":"2021-02-14 06:47","market":"us","language":"en","title":"Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2111807728","media":"Reuters","summary":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Transla","content":"<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-14 06:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TBIO":"TELESIS BIO","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111807728","content_text":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Translate Bio  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.   In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.     \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.   The CEO gave no other details. Officials at Sanofi were not available for comment.   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.     To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.     Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly. (Reporting by Matthias Blamont; Editing by Dominique Vidalon)((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))","news_type":1},"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386631333,"gmtCreate":1613168819622,"gmtModify":1634554296588,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386631333","repostId":"2111071977","repostType":2,"isVote":1,"tweetType":1,"viewCount":354,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386076859,"gmtCreate":1613121547571,"gmtModify":1634554454410,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/386076859","repostId":"2110026963","repostType":2,"repost":{"id":"2110026963","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1613109422,"share":"https://www.laohu8.com/m/news/2110026963?lang=&edition=full","pubTime":"2021-02-12 13:57","market":"us","language":"en","title":"Here's the formula for spotting genuinely undervalued companies, claims this investment house","url":"https://stock-news.laohu8.com/highlight/detail?id=2110026963","media":"Dow Jones","summary":"The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis. For most of 2020, investors poured money into names like online retailer Amazon $$, electric-car maker Tesla $$, and e-commerce platform Shopify -- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.But when news broke in early November 2020 that drug company Pfizer $$ and its partner BioNTech $$ had developed an effective vaccine against COVID-19, something pro","content":"<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's the formula for spotting genuinely undervalued companies, claims this investment house</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's the formula for spotting genuinely undervalued companies, claims this investment house\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-02-12 13:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/15e20574f8fb568333181d61bb200086","relate_stocks":{"PFE":"辉瑞","AMZN":"亚马逊","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2110026963","content_text":"MW Here's the formula for spotting genuinely undervalued companies, claims this investment house\nThe growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis\nFor most of 2020, investors poured money into names like online retailer Amazon $(AMZN)$, electric-car maker Tesla $(TSLA)$, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.\nBut when news broke in early November 2020 that drug company Pfizer $(PFE)$ and its partner BioNTech $(BNTX)$ had developed an effective vaccine against COVID-19, something profound happened in financial markets.\nInvestors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.\nThis rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.\nAnd it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.\nThe apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.\n\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.\n\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"\nAnalysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.\nThe value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.\nIn reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.\nStocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.\nTo have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.","news_type":1},"isVote":1,"tweetType":1,"viewCount":497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386076310,"gmtCreate":1613121496330,"gmtModify":1634554454632,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386076310","repostId":"2110020257","repostType":2,"repost":{"id":"2110020257","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613120155,"share":"https://www.laohu8.com/m/news/2110020257?lang=&edition=full","pubTime":"2021-02-12 16:55","market":"fut","language":"en","title":"FOREX-Bitcoin clings to Tesla gains, dollar set for weekly loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2110020257","media":"Reuters","summary":"* Bitcoin set for 20% weekly rise   * Traders reassess pace of U.S. recovery on weak jobs data   * E","content":"<html><body><p>* Bitcoin set for 20% weekly rise</p><p>   * Traders reassess pace of U.S. recovery on weak jobs data</p><p>   * Euro ticks down </p><p>   * Graphic: World FX rates </p><p>    By Julien Ponthus</p><p>   LONDON, Feb 12 (Reuters) - Bitcoin    hovered close to record highs on Friday, set for gains of over 20% in a milestone week marked by the endorsement of major firms, such as Elon Musk's Tesla, while the weak U.S. jobs market continued to weigh on the dollar. </p><p>   The world's most popular cryptocurrency last traded 1.1% down at $47,451, just south of a record high of $49,000 reached after U.S. banking group BNY Mellon    said it had formed a unit to help clients hold, transfer, and issue digital assets.</p><p>  Tesla    revealed it had bought $1.5 billion worth of the cryptocurrency and BlackRock   , the world's largest asset manager, added bitcoin as an eligible investment to two funds.  </p><p>   Credit card giant Mastercard's    plans to offer support for some cryptocurrencies also boosted bitcoin's ambitions towards mainstream finance, but many banks are reluctant to engage with it. </p><p>   \"We do not cover other speculative objects such as vintage cars, works of art or expensive watches\", Commerzbank Research said in a note on why it would not comment on the bitcoin exchange rate that some analysts say could test the $50,000 level soon.</p><p>   Elsewhere the dollar headed for its first losing week in three as signs of weakness in the U.S. jobs market dented investor expectations about the pace of economic recovery from the pandemic. </p><p>   In early European trade, the dollar index    edged up 0.15% to 90.55 after subdued volumes in Asia due to the Lunar New Year. It was on track to fall 0.5% for the week.</p><p>   The dollar was slightly up against the yen at 104.940</p><p> . </p><p>   The weaker-than-expected weekly U.S. jobless claims data on Thursday added to concerns the dollar's previous rally had priced in too fast a rebound for the U.S. economy.</p><p>   There has been a divergence in views among traders this year over how U.S. President Joe Biden's planned $1.9 trillion fiscal stimulus package will affect the dollar.</p><p>   Some see it as bolstering the currency as it should speed a U.S. recovery relative to other countries, while others reckoned it would feed a global reflation narrative that should lift riskier assets at the dollar's expense.</p><p>   The euro    slipped 0.17% to $1.2115, consolidating for a third day near that level as it headed for a 0.5% weekly advance.</p><p>   The common currency was flat against the pound at 0.876   after official figures showed Britain's coronavirus-ravaged economy slumped by 9.9% in 2020, the biggest annual crash in more than 300 years, but avoided heading back towards recession at the end of last year.   </p><p>   Norway's crown strengthened slightly and pared some losses against the euro after data showed the country's economy contracted by 2.5% last year, a decline less severe than in most other European nations.</p><p>   It traded last at 10.2940, down 0.1% against the euro.</p><p>    ========================================================</p><p>   Currency bid prices at 8:31AM (831 GMT)</p><p>Description      RIC         Last           U.S. Close  Pct Change     YTD Pct     High Bid    Low Bid</p><p>                                             Previous                   Change                 </p><p>                                             Session                                           </p><p>Euro/Dollar           $1.2109        $1.2133     -0.19%         -0.89%      +1.2135     +1.2105</p><p>Dollar/Yen             104.9600       104.7300    +0.23%         +1.63%      +104.9800   +104.7850</p><p>Euro/Yen              127.09         127.05      +0.03%         +0.13%      +127.2300   +127.0200</p><p>Dollar/Swiss          0.8911         0.8898      +0.16%         +0.73%      +0.8913     +0.8901</p><p>Sterling/Dollar        1.3790         1.3816      -0.17%         +0.96%      +1.3816     +1.3785</p><p>Dollar/Canadian        1.2739         1.2703      +0.28%         +0.04%      +1.2740     +1.2695</p><p>Aussie/Dollar          0.7734         0.7755      -0.25%         +0.55%      +0.7756     +0.7734</p><p>NZ                     0.7200         0.7227      -0.33%         +0.31%      +0.7232     +0.7203</p><p>Dollar/Dollar                                                                                  </p><p>    All spots    Tokyo spots    Europe spots     Volatilities     Tokyo Forex market info from BOJ   </p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ World FX rates    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Julien Ponthus; Editing by Sam Holmes, Simon Cameron-Moore and Barbara lewis)</p><p>((Kevin.Buckland@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FOREX-Bitcoin clings to Tesla gains, dollar set for weekly loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFOREX-Bitcoin clings to Tesla gains, dollar set for weekly loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-12 16:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>* Bitcoin set for 20% weekly rise</p><p>   * Traders reassess pace of U.S. recovery on weak jobs data</p><p>   * Euro ticks down </p><p>   * Graphic: World FX rates </p><p>    By Julien Ponthus</p><p>   LONDON, Feb 12 (Reuters) - Bitcoin    hovered close to record highs on Friday, set for gains of over 20% in a milestone week marked by the endorsement of major firms, such as Elon Musk's Tesla, while the weak U.S. jobs market continued to weigh on the dollar. </p><p>   The world's most popular cryptocurrency last traded 1.1% down at $47,451, just south of a record high of $49,000 reached after U.S. banking group BNY Mellon    said it had formed a unit to help clients hold, transfer, and issue digital assets.</p><p>  Tesla    revealed it had bought $1.5 billion worth of the cryptocurrency and BlackRock   , the world's largest asset manager, added bitcoin as an eligible investment to two funds.  </p><p>   Credit card giant Mastercard's    plans to offer support for some cryptocurrencies also boosted bitcoin's ambitions towards mainstream finance, but many banks are reluctant to engage with it. </p><p>   \"We do not cover other speculative objects such as vintage cars, works of art or expensive watches\", Commerzbank Research said in a note on why it would not comment on the bitcoin exchange rate that some analysts say could test the $50,000 level soon.</p><p>   Elsewhere the dollar headed for its first losing week in three as signs of weakness in the U.S. jobs market dented investor expectations about the pace of economic recovery from the pandemic. </p><p>   In early European trade, the dollar index    edged up 0.15% to 90.55 after subdued volumes in Asia due to the Lunar New Year. It was on track to fall 0.5% for the week.</p><p>   The dollar was slightly up against the yen at 104.940</p><p> . </p><p>   The weaker-than-expected weekly U.S. jobless claims data on Thursday added to concerns the dollar's previous rally had priced in too fast a rebound for the U.S. economy.</p><p>   There has been a divergence in views among traders this year over how U.S. President Joe Biden's planned $1.9 trillion fiscal stimulus package will affect the dollar.</p><p>   Some see it as bolstering the currency as it should speed a U.S. recovery relative to other countries, while others reckoned it would feed a global reflation narrative that should lift riskier assets at the dollar's expense.</p><p>   The euro    slipped 0.17% to $1.2115, consolidating for a third day near that level as it headed for a 0.5% weekly advance.</p><p>   The common currency was flat against the pound at 0.876   after official figures showed Britain's coronavirus-ravaged economy slumped by 9.9% in 2020, the biggest annual crash in more than 300 years, but avoided heading back towards recession at the end of last year.   </p><p>   Norway's crown strengthened slightly and pared some losses against the euro after data showed the country's economy contracted by 2.5% last year, a decline less severe than in most other European nations.</p><p>   It traded last at 10.2940, down 0.1% against the euro.</p><p>    ========================================================</p><p>   Currency bid prices at 8:31AM (831 GMT)</p><p>Description      RIC         Last           U.S. Close  Pct Change     YTD Pct     High Bid    Low Bid</p><p>                                             Previous                   Change                 </p><p>                                             Session                                           </p><p>Euro/Dollar           $1.2109        $1.2133     -0.19%         -0.89%      +1.2135     +1.2105</p><p>Dollar/Yen             104.9600       104.7300    +0.23%         +1.63%      +104.9800   +104.7850</p><p>Euro/Yen              127.09         127.05      +0.03%         +0.13%      +127.2300   +127.0200</p><p>Dollar/Swiss          0.8911         0.8898      +0.16%         +0.73%      +0.8913     +0.8901</p><p>Sterling/Dollar        1.3790         1.3816      -0.17%         +0.96%      +1.3816     +1.3785</p><p>Dollar/Canadian        1.2739         1.2703      +0.28%         +0.04%      +1.2740     +1.2695</p><p>Aussie/Dollar          0.7734         0.7755      -0.25%         +0.55%      +0.7756     +0.7734</p><p>NZ                     0.7200         0.7227      -0.33%         +0.31%      +0.7232     +0.7203</p><p>Dollar/Dollar                                                                                  </p><p>    All spots    Tokyo spots    Europe spots     Volatilities     Tokyo Forex market info from BOJ   </p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ World FX rates    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Julien Ponthus; Editing by Sam Holmes, Simon Cameron-Moore and Barbara lewis)</p><p>((Kevin.Buckland@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2110020257","content_text":"* Bitcoin set for 20% weekly rise   * Traders reassess pace of U.S. recovery on weak jobs data   * Euro ticks down    * Graphic: World FX rates     By Julien Ponthus   LONDON, Feb 12 (Reuters) - Bitcoin    hovered close to record highs on Friday, set for gains of over 20% in a milestone week marked by the endorsement of major firms, such as Elon Musk's Tesla, while the weak U.S. jobs market continued to weigh on the dollar.    The world's most popular cryptocurrency last traded 1.1% down at $47,451, just south of a record high of $49,000 reached after U.S. banking group BNY Mellon    said it had formed a unit to help clients hold, transfer, and issue digital assets.  Tesla    revealed it had bought $1.5 billion worth of the cryptocurrency and BlackRock   , the world's largest asset manager, added bitcoin as an eligible investment to two funds.     Credit card giant Mastercard's    plans to offer support for some cryptocurrencies also boosted bitcoin's ambitions towards mainstream finance, but many banks are reluctant to engage with it.    \"We do not cover other speculative objects such as vintage cars, works of art or expensive watches\", Commerzbank Research said in a note on why it would not comment on the bitcoin exchange rate that some analysts say could test the $50,000 level soon.   Elsewhere the dollar headed for its first losing week in three as signs of weakness in the U.S. jobs market dented investor expectations about the pace of economic recovery from the pandemic.    In early European trade, the dollar index    edged up 0.15% to 90.55 after subdued volumes in Asia due to the Lunar New Year. It was on track to fall 0.5% for the week.   The dollar was slightly up against the yen at 104.940 .    The weaker-than-expected weekly U.S. jobless claims data on Thursday added to concerns the dollar's previous rally had priced in too fast a rebound for the U.S. economy.   There has been a divergence in views among traders this year over how U.S. President Joe Biden's planned $1.9 trillion fiscal stimulus package will affect the dollar.   Some see it as bolstering the currency as it should speed a U.S. recovery relative to other countries, while others reckoned it would feed a global reflation narrative that should lift riskier assets at the dollar's expense.   The euro    slipped 0.17% to $1.2115, consolidating for a third day near that level as it headed for a 0.5% weekly advance.   The common currency was flat against the pound at 0.876   after official figures showed Britain's coronavirus-ravaged economy slumped by 9.9% in 2020, the biggest annual crash in more than 300 years, but avoided heading back towards recession at the end of last year.      Norway's crown strengthened slightly and pared some losses against the euro after data showed the country's economy contracted by 2.5% last year, a decline less severe than in most other European nations.   It traded last at 10.2940, down 0.1% against the euro.    ========================================================   Currency bid prices at 8:31AM (831 GMT)Description      RIC         Last           U.S. Close  Pct Change     YTD Pct     High Bid    Low Bid                                             Previous                   Change                                                              Session                                           Euro/Dollar           $1.2109        $1.2133     -0.19%         -0.89%      +1.2135     +1.2105Dollar/Yen             104.9600       104.7300    +0.23%         +1.63%      +104.9800   +104.7850Euro/Yen              127.09         127.05      +0.03%         +0.13%      +127.2300   +127.0200Dollar/Swiss          0.8911         0.8898      +0.16%         +0.73%      +0.8913     +0.8901Sterling/Dollar        1.3790         1.3816      -0.17%         +0.96%      +1.3816     +1.3785Dollar/Canadian        1.2739         1.2703      +0.28%         +0.04%      +1.2740     +1.2695Aussie/Dollar          0.7734         0.7755      -0.25%         +0.55%      +0.7756     +0.7734NZ                     0.7200         0.7227      -0.33%         +0.31%      +0.7232     +0.7203Dollar/Dollar                                                                                      All spots    Tokyo spots    Europe spots     Volatilities     Tokyo Forex market info from BOJ       <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ World FX rates       ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>(Reporting by Julien Ponthus; Editing by Sam Holmes, Simon Cameron-Moore and Barbara lewis)((Kevin.Buckland@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":806,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":389370214,"gmtCreate":1612702161938,"gmtModify":1703764372282,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389370214","repostId":"2109704729","repostType":2,"isVote":1,"tweetType":1,"viewCount":400,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389370655,"gmtCreate":1612702142177,"gmtModify":1703764372453,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389370655","repostId":"2109704729","repostType":2,"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380418956,"gmtCreate":1612573153275,"gmtModify":1703763743360,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"[呆住]&nbsp;","listText":"[呆住]&nbsp;","text":"[呆住]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/380418956","repostId":"2109777511","repostType":2,"repost":{"id":"2109777511","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612561140,"share":"https://www.laohu8.com/m/news/2109777511?lang=&edition=full","pubTime":"2021-02-06 05:39","market":"fut","language":"en","title":"BUZZ-U.S. stocks weekly: Gaming more aid","url":"https://stock-news.laohu8.com/highlight/detail?id=2109777511","media":"Reuters","summary":"** S&P 500    jumps 4.6%, enjoys best week since U.S. elections as investors bet on more government ","content":"<html><body><p>** S&amp;P 500    jumps 4.6%, enjoys best week since U.S. elections as investors bet on more government aid to bolster economy   </p><p>   ** That said, the SPX may have tired legs  </p><p>   ** This as the Dow    faces a rough ceiling  </p><p>   ** Indeed, it was 5000 points, and a cloud of dust</p><p>, though the Nasdaq    may have a crack under the surface  </p><p>   ** But by Fri, the Dow was swinging for its highs</p><p>   ** Every sector hits paydirt: energy and communication services are the MVPs</p><p>   ** Energy    surges 8.3%. Oil cos rise as crude hits 1-yr high on growth hopes, OPEC+ supply cuts  . Exxon</p><p>  gains as Wall Street sees co moving in right direction</p><p>, and reportedly had discussed merger with Chevron</p><p>  in early 2020  </p><p>   ** Communication services    rally 7.3%. Alphabet</p><p>  best in sector, up 14%, as Google search still king, but Cloud and YouTube strong supporting cast  </p><p>   ** Consumer Discretionary    up 6%. Amazon.com</p><p>  founder Bezos to give reins to cloud boss Jassy as sales rocket past $100 bln  </p><p>   ** Tech    lifts 4.9%. <a href=\"https://laohu8.com/S/PYPL\">PayPal</a>    leaps 15% on upbeat Q4 results as pandemic-driven shift to online shopping sends payment volumes surging  . But Qualcomm</p><p>  falls after sales miss on chip supply constraints</p><p>   ** Meanwhile, the GameStop    roller coaster continues</p><p>  , and when it comes to Super Bowl LV, will the market score, or fumble?   </p><p>   ** SPX performance YTD:    </p><p>(Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)</p><p>((lance.tupper.tr.com@reuters.net lance.tupper@tr.com terence.gabriel.tr.com@reuters.net terence.gabriel@tr.com))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-U.S. stocks weekly: Gaming more aid</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-U.S. stocks weekly: Gaming more aid\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-06 05:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>** S&amp;P 500    jumps 4.6%, enjoys best week since U.S. elections as investors bet on more government aid to bolster economy   </p><p>   ** That said, the SPX may have tired legs  </p><p>   ** This as the Dow    faces a rough ceiling  </p><p>   ** Indeed, it was 5000 points, and a cloud of dust</p><p>, though the Nasdaq    may have a crack under the surface  </p><p>   ** But by Fri, the Dow was swinging for its highs</p><p>   ** Every sector hits paydirt: energy and communication services are the MVPs</p><p>   ** Energy    surges 8.3%. Oil cos rise as crude hits 1-yr high on growth hopes, OPEC+ supply cuts  . Exxon</p><p>  gains as Wall Street sees co moving in right direction</p><p>, and reportedly had discussed merger with Chevron</p><p>  in early 2020  </p><p>   ** Communication services    rally 7.3%. Alphabet</p><p>  best in sector, up 14%, as Google search still king, but Cloud and YouTube strong supporting cast  </p><p>   ** Consumer Discretionary    up 6%. Amazon.com</p><p>  founder Bezos to give reins to cloud boss Jassy as sales rocket past $100 bln  </p><p>   ** Tech    lifts 4.9%. <a href=\"https://laohu8.com/S/PYPL\">PayPal</a>    leaps 15% on upbeat Q4 results as pandemic-driven shift to online shopping sends payment volumes surging  . But Qualcomm</p><p>  falls after sales miss on chip supply constraints</p><p>   ** Meanwhile, the GameStop    roller coaster continues</p><p>  , and when it comes to Super Bowl LV, will the market score, or fumble?   </p><p>   ** SPX performance YTD:    </p><p>(Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)</p><p>((lance.tupper.tr.com@reuters.net lance.tupper@tr.com terence.gabriel.tr.com@reuters.net terence.gabriel@tr.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站",".SPX":"S&P 500 Index","DDG":"ProShares做空石油与天然气ETF","SQQQ":"纳指三倍做空ETF","QLD":"纳指两倍做多ETF","QCOM":"高通","DXD":"道指两倍做空ETF","QNETCN":"纳斯达克中美互联网老虎指数","UCO":"二倍做多彭博原油ETF","PSQ":"纳指反向ETF","CVX":"雪佛龙","DUG":"二倍做空石油与天然气ETF(ProShares)","SDOW":"道指三倍做空ETF-ProShares","09086":"华夏纳指-U","XOM":"埃克森美孚","DWT":"三倍做空原油ETN","DDM":"道指两倍做多ETF","DJX":"1/100道琼斯","TQQQ":"纳指三倍做多ETF","SCO":"二倍做空彭博原油指数ETF","PYPL":"PayPal","QQQ":"纳指100ETF","03086":"华夏纳指","DOG":"道指反向ETF","AMZN":"亚马逊","UDOW":"道指三倍做多ETF-ProShares","QID":"纳指两倍做空ETF",".DJI":"道琼斯","USO":"美国原油ETF","GOOGL":"谷歌A",".IXIC":"NASDAQ Composite"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2109777511","content_text":"** S&P 500    jumps 4.6%, enjoys best week since U.S. elections as investors bet on more government aid to bolster economy      ** That said, the SPX may have tired legs     ** This as the Dow    faces a rough ceiling     ** Indeed, it was 5000 points, and a cloud of dust, though the Nasdaq    may have a crack under the surface     ** But by Fri, the Dow was swinging for its highs   ** Every sector hits paydirt: energy and communication services are the MVPs   ** Energy    surges 8.3%. Oil cos rise as crude hits 1-yr high on growth hopes, OPEC+ supply cuts  . Exxon  gains as Wall Street sees co moving in right direction, and reportedly had discussed merger with Chevron  in early 2020     ** Communication services    rally 7.3%. Alphabet  best in sector, up 14%, as Google search still king, but Cloud and YouTube strong supporting cast     ** Consumer Discretionary    up 6%. Amazon.com  founder Bezos to give reins to cloud boss Jassy as sales rocket past $100 bln     ** Tech    lifts 4.9%. PayPal    leaps 15% on upbeat Q4 results as pandemic-driven shift to online shopping sends payment volumes surging  . But Qualcomm  falls after sales miss on chip supply constraints   ** Meanwhile, the GameStop    roller coaster continues  , and when it comes to Super Bowl LV, will the market score, or fumble?      ** SPX performance YTD:    (Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)((lance.tupper.tr.com@reuters.net lance.tupper@tr.com terence.gabriel.tr.com@reuters.net terence.gabriel@tr.com))","news_type":1},"isVote":1,"tweetType":1,"viewCount":877,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":380841348,"gmtCreate":1612535373684,"gmtModify":1703763268768,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/380841348","repostId":"2109762467","repostType":2,"repost":{"id":"2109762467","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612534346,"share":"https://www.laohu8.com/m/news/2109762467?lang=&edition=full","pubTime":"2021-02-05 22:12","market":"sh","language":"en","title":"Too delicate: Germany ducks Taiwan appeal for COVID-19 vaccine supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2109762467","media":"Reuters","summary":"By Michael Nienaber   BERLIN, Feb 5 (Reuters) - Germany on Friday ducked an appeal by Taiwan for its","content":"<html><body><p>By Michael Nienaber</p><p>   BERLIN, Feb 5 (Reuters) - Germany on Friday ducked an appeal by Taiwan for its help to supply COVID-19 vaccines, as the Asian tech powerhouse's request for assistance following Berlin's plea to ease a semiconductor supply crunch in the auto industry risked provoking China's ire.</p><p>   In an exchange between the economy ministers of Germany and Taiwan last month, Berlin first asked Taipei to persuade its chip foundries to increase supply to German car makers that have had to rein in production due to chip shortages.</p><p>   While promising help on chips, Taiwan Economy Minister Wang Mei-hua appealed to Germany's de facto ambassador in Taipei for assistance in obtaining vaccines, none of which has arrived on the island yet.  </p><p>   The exchange risks angering Beijing, which considers self-ruled Taiwan a wayward province. Though German industry relies on chips made by the likes of Taiwan Semiconductor Manufacturing Corp   , China is its largest trading partner and a big export market for its cars.</p><p>   Asked at a regular news conference whether the Germany would entertain the idea of some kind of chips-for-vaccines deal, spokesmen for both the economy and foreign ministries declined comment.</p><p>   A person familiar with discussions between the two governments said the diplomatic implications of any such agreement were tricky, as were the optics of exporting vaccines that remain in short supply at home.</p><p>   The first COVID-19 vaccine to win European approval was devised by German biotech startup BioNTech   , which is marketing the shot in partnership with U.S. drug company Pfizer Inc   . </p><p>   BioNTech, meanwhile, has an existing arrangement to market 100 million doses of its vaccine in China through Fosun Pharma. A company spokeswoman said initial talks were under way with Fosun on expanding that cooperation.   </p><p>   \"We may consider shipping the bulk vaccine substance to mainland China and packaging there, or even producing the vaccine in mainland China through our partner Fosun Pharma, but these ideas are all under discussion,\" the spokeswoman said.</p><p>   Asked whether it might supply vaccine to Taiwan, BioNTech declined to comment \"on potential or planned specifics of our commercial discussions\".</p><p>   China has vowed to bring Taiwan under its rule and has not renounced the use of force to do so.</p><p> (Additional reporting and writing by Douglas Busvine; Additional reporting by Andreas Rinke; Editing by Ben Blanchard and Nick Macfie)</p><p>((douglas.busvine@tr.com; +49 30 220 133 562;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Too delicate: Germany ducks Taiwan appeal for COVID-19 vaccine supply</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToo delicate: Germany ducks Taiwan appeal for COVID-19 vaccine supply\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-05 22:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>By Michael Nienaber</p><p>   BERLIN, Feb 5 (Reuters) - Germany on Friday ducked an appeal by Taiwan for its help to supply COVID-19 vaccines, as the Asian tech powerhouse's request for assistance following Berlin's plea to ease a semiconductor supply crunch in the auto industry risked provoking China's ire.</p><p>   In an exchange between the economy ministers of Germany and Taiwan last month, Berlin first asked Taipei to persuade its chip foundries to increase supply to German car makers that have had to rein in production due to chip shortages.</p><p>   While promising help on chips, Taiwan Economy Minister Wang Mei-hua appealed to Germany's de facto ambassador in Taipei for assistance in obtaining vaccines, none of which has arrived on the island yet.  </p><p>   The exchange risks angering Beijing, which considers self-ruled Taiwan a wayward province. Though German industry relies on chips made by the likes of Taiwan Semiconductor Manufacturing Corp   , China is its largest trading partner and a big export market for its cars.</p><p>   Asked at a regular news conference whether the Germany would entertain the idea of some kind of chips-for-vaccines deal, spokesmen for both the economy and foreign ministries declined comment.</p><p>   A person familiar with discussions between the two governments said the diplomatic implications of any such agreement were tricky, as were the optics of exporting vaccines that remain in short supply at home.</p><p>   The first COVID-19 vaccine to win European approval was devised by German biotech startup BioNTech   , which is marketing the shot in partnership with U.S. drug company Pfizer Inc   . </p><p>   BioNTech, meanwhile, has an existing arrangement to market 100 million doses of its vaccine in China through Fosun Pharma. A company spokeswoman said initial talks were under way with Fosun on expanding that cooperation.   </p><p>   \"We may consider shipping the bulk vaccine substance to mainland China and packaging there, or even producing the vaccine in mainland China through our partner Fosun Pharma, but these ideas are all under discussion,\" the spokeswoman said.</p><p>   Asked whether it might supply vaccine to Taiwan, BioNTech declined to comment \"on potential or planned specifics of our commercial discussions\".</p><p>   China has vowed to bring Taiwan under its rule and has not renounced the use of force to do so.</p><p> (Additional reporting and writing by Douglas Busvine; Additional reporting by Andreas Rinke; Editing by Ben Blanchard and Nick Macfie)</p><p>((douglas.busvine@tr.com; +49 30 220 133 562;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2109762467","content_text":"By Michael Nienaber   BERLIN, Feb 5 (Reuters) - Germany on Friday ducked an appeal by Taiwan for its help to supply COVID-19 vaccines, as the Asian tech powerhouse's request for assistance following Berlin's plea to ease a semiconductor supply crunch in the auto industry risked provoking China's ire.   In an exchange between the economy ministers of Germany and Taiwan last month, Berlin first asked Taipei to persuade its chip foundries to increase supply to German car makers that have had to rein in production due to chip shortages.   While promising help on chips, Taiwan Economy Minister Wang Mei-hua appealed to Germany's de facto ambassador in Taipei for assistance in obtaining vaccines, none of which has arrived on the island yet.     The exchange risks angering Beijing, which considers self-ruled Taiwan a wayward province. Though German industry relies on chips made by the likes of Taiwan Semiconductor Manufacturing Corp   , China is its largest trading partner and a big export market for its cars.   Asked at a regular news conference whether the Germany would entertain the idea of some kind of chips-for-vaccines deal, spokesmen for both the economy and foreign ministries declined comment.   A person familiar with discussions between the two governments said the diplomatic implications of any such agreement were tricky, as were the optics of exporting vaccines that remain in short supply at home.   The first COVID-19 vaccine to win European approval was devised by German biotech startup BioNTech   , which is marketing the shot in partnership with U.S. drug company Pfizer Inc   .    BioNTech, meanwhile, has an existing arrangement to market 100 million doses of its vaccine in China through Fosun Pharma. A company spokeswoman said initial talks were under way with Fosun on expanding that cooperation.      \"We may consider shipping the bulk vaccine substance to mainland China and packaging there, or even producing the vaccine in mainland China through our partner Fosun Pharma, but these ideas are all under discussion,\" the spokeswoman said.   Asked whether it might supply vaccine to Taiwan, BioNTech declined to comment \"on potential or planned specifics of our commercial discussions\".   China has vowed to bring Taiwan under its rule and has not renounced the use of force to do so. (Additional reporting and writing by Douglas Busvine; Additional reporting by Andreas Rinke; Editing by Ben Blanchard and Nick Macfie)((douglas.busvine@tr.com; +49 30 220 133 562;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":317022586,"gmtCreate":1612400076245,"gmtModify":1703761298065,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Another big player","listText":"Another big player","text":"Another big player","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/317022586","repostId":"2108795093","repostType":2,"repost":{"id":"2108795093","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1612394820,"share":"https://www.laohu8.com/m/news/2108795093?lang=&edition=full","pubTime":"2021-02-04 07:27","market":"us","language":"en","title":"Apple may build a fully autonomous electric car with Hyundai-Kia: report","url":"https://stock-news.laohu8.com/highlight/detail?id=2108795093","media":"Dow Jones","summary":"Apple Inc. is close to a deal with Hyundai-Kia to make an Apple-branded autonomous electric vehicle at a Kia plant in Georgia, CNBC reported late Wednesday, citing \"multiple\" sources who briefed CNBC on the plan.The so-called \"Apple car\" is being developed by a team at Apple  and would go into production in 2024, although that date could be pushed back, CNBC said.South Korean media reported earlier Wednesday that the Korean auto maker had received a $3.6 billion investment from Apple as part of ","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: Apple may build a fully autonomous electric car with Hyundai-Kia: report\n</p>\n<p>\n  By Claudia Assis \n</p>\n<p>\n  Apple Inc. is close to a deal with Hyundai-Kia to make an Apple-branded autonomous electric vehicle at a Kia plant in Georgia, CNBC reported late Wednesday, citing \"multiple\" sources who briefed CNBC on the plan. \n</p>\n<p>\n  The so-called \"Apple car\" is being developed by a team at Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a> and would go into production in 2024, although that date could be pushed back, CNBC said.   \n</p>\n<p>\n  No firm agreement has been reached between the companies, and Apple could opt to partner with another auto maker separately or in addition to working with Hyundai , CNBC said. \n</p>\n<p>\n  South Korean media reported earlier Wednesday that the Korean auto maker had received a $3.6 billion investment from Apple as part of a collaboration to make electric vehicles. Hyundai owns about a third of Kia  stock. \n</p>\n<p>\n  -Claudia Assis; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 03, 2021 18:27 ET (23:27 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple may build a fully autonomous electric car with Hyundai-Kia: report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple may build a fully autonomous electric car with Hyundai-Kia: report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-02-04 07:27</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: Apple may build a fully autonomous electric car with Hyundai-Kia: report\n</p>\n<p>\n  By Claudia Assis \n</p>\n<p>\n  Apple Inc. is close to a deal with Hyundai-Kia to make an Apple-branded autonomous electric vehicle at a Kia plant in Georgia, CNBC reported late Wednesday, citing \"multiple\" sources who briefed CNBC on the plan. \n</p>\n<p>\n  The so-called \"Apple car\" is being developed by a team at Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a> and would go into production in 2024, although that date could be pushed back, CNBC said.   \n</p>\n<p>\n  No firm agreement has been reached between the companies, and Apple could opt to partner with another auto maker separately or in addition to working with Hyundai , CNBC said. \n</p>\n<p>\n  South Korean media reported earlier Wednesday that the Korean auto maker had received a $3.6 billion investment from Apple as part of a collaboration to make electric vehicles. Hyundai owns about a third of Kia  stock. \n</p>\n<p>\n  -Claudia Assis; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 03, 2021 18:27 ET (23:27 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","03086":"华夏纳指","09086":"华夏纳指-U","HYMLY":"Hyundai Motor Co., Ltd."},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108795093","content_text":"MW UPDATE: Apple may build a fully autonomous electric car with Hyundai-Kia: report\n\n\n  By Claudia Assis \n\n\n  Apple Inc. is close to a deal with Hyundai-Kia to make an Apple-branded autonomous electric vehicle at a Kia plant in Georgia, CNBC reported late Wednesday, citing \"multiple\" sources who briefed CNBC on the plan. \n\n\n  The so-called \"Apple car\" is being developed by a team at Apple $(AAPL)$ and would go into production in 2024, although that date could be pushed back, CNBC said.   \n\n\n  No firm agreement has been reached between the companies, and Apple could opt to partner with another auto maker separately or in addition to working with Hyundai , CNBC said. \n\n\n  South Korean media reported earlier Wednesday that the Korean auto maker had received a $3.6 billion investment from Apple as part of a collaboration to make electric vehicles. Hyundai owns about a third of Kia  stock. \n\n\n  -Claudia Assis; 415-439-6400; AskNewswires@dowjones.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  February 03, 2021 18:27 ET (23:27 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317022073,"gmtCreate":1612400045493,"gmtModify":1703761297055,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/317022073","repostId":"2108579668","repostType":2,"repost":{"id":"2108579668","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612396458,"share":"https://www.laohu8.com/m/news/2108579668?lang=&edition=full","pubTime":"2021-02-04 07:54","market":"us","language":"en","title":"UPDATE 1-Social network Parler terminates CEO John Matze","url":"https://stock-news.laohu8.com/highlight/detail?id=2108579668","media":"Reuters","summary":"(Adds quote and context)   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conserva","content":"<html><body><p>(Adds quote and context)</p><p>   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conservatives, has dismissed CEO John Matze, according to Matze on Wednesday, as the site has largely gone  offline after the Jan. 6 attack on the U.S. Capitol. </p><p>   Matze confirmed the move in a text message to Reuters.</p><p>   \"On January 29, 2021, the Parler board controlled by Rebekah Mercer decided to immediately terminate my position as CEO of Parler. I did not participate in this decision,\" Matze said in a memo sent to Parler staff, originally reported by Fox News.</p><p>   The company did not immediately respond to a request for comment.</p><p>   Parler remains largely offline after being dropped by Seattle-based Amazon's    cloud-hosting division and the app stores of Apple Inc    and Alphabet Inc's    Google following the Jan. 6 siege of the U.S. Capitol.</p><p>   Parler, which was founded in 2018, has styled itself as a \"free speech-driven\" space. The app has largely attracted U.S. conservatives who disagree with rules around content on social media sites like <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc     and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc   .</p><p> (Reporting by Kanishka Singh in Bengaluru, Elizabeth Culliford in New York and Katie Paul in Palo Alto Editing by Chris Reese and Cynthia Osterman)</p><p>((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-Social network Parler terminates CEO John Matze</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-Social network Parler terminates CEO John Matze\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-04 07:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds quote and context)</p><p>   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conservatives, has dismissed CEO John Matze, according to Matze on Wednesday, as the site has largely gone  offline after the Jan. 6 attack on the U.S. Capitol. </p><p>   Matze confirmed the move in a text message to Reuters.</p><p>   \"On January 29, 2021, the Parler board controlled by Rebekah Mercer decided to immediately terminate my position as CEO of Parler. I did not participate in this decision,\" Matze said in a memo sent to Parler staff, originally reported by Fox News.</p><p>   The company did not immediately respond to a request for comment.</p><p>   Parler remains largely offline after being dropped by Seattle-based Amazon's    cloud-hosting division and the app stores of Apple Inc    and Alphabet Inc's    Google following the Jan. 6 siege of the U.S. Capitol.</p><p>   Parler, which was founded in 2018, has styled itself as a \"free speech-driven\" space. The app has largely attracted U.S. conservatives who disagree with rules around content on social media sites like <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc     and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc   .</p><p> (Reporting by Kanishka Singh in Bengaluru, Elizabeth Culliford in New York and Katie Paul in Palo Alto Editing by Chris Reese and Cynthia Osterman)</p><p>((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","09086":"华夏纳指-U"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108579668","content_text":"(Adds quote and context)   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conservatives, has dismissed CEO John Matze, according to Matze on Wednesday, as the site has largely gone  offline after the Jan. 6 attack on the U.S. Capitol.    Matze confirmed the move in a text message to Reuters.   \"On January 29, 2021, the Parler board controlled by Rebekah Mercer decided to immediately terminate my position as CEO of Parler. I did not participate in this decision,\" Matze said in a memo sent to Parler staff, originally reported by Fox News.   The company did not immediately respond to a request for comment.   Parler remains largely offline after being dropped by Seattle-based Amazon's    cloud-hosting division and the app stores of Apple Inc    and Alphabet Inc's    Google following the Jan. 6 siege of the U.S. Capitol.   Parler, which was founded in 2018, has styled itself as a \"free speech-driven\" space. The app has largely attracted U.S. conservatives who disagree with rules around content on social media sites like Facebook Inc     and Twitter Inc   . (Reporting by Kanishka Singh in Bengaluru, Elizabeth Culliford in New York and Katie Paul in Palo Alto Editing by Chris Reese and Cynthia Osterman)((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317026310,"gmtCreate":1612400012630,"gmtModify":1703761295878,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/317026310","repostId":"2108796672","repostType":2,"repost":{"id":"2108796672","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612396860,"share":"https://www.laohu8.com/m/news/2108796672?lang=&edition=full","pubTime":"2021-02-04 08:01","market":"us","language":"en","title":"Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2108796672","media":"Reuters","summary":"LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses genera","content":"<html><body><p>LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></p><p>  are combined in a two-shot schedule.    </p><p>   The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.    </p><p>   The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks. </p><p>   Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine. </p><p>   It is expected more vaccines will be added to the trial when they are approved and rolled out.</p><p>   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.</p><p>   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.</p><p>   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.</p><p>   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.</p><p>   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.</p><p>   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.  </p><p> (Reporting by Alistair Smout Editing by Bill Berkrot)</p><p>((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBritain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-04 08:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></p><p>  are combined in a two-shot schedule.    </p><p>   The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.    </p><p>   The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks. </p><p>   Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine. </p><p>   It is expected more vaccines will be added to the trial when they are approved and rolled out.</p><p>   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.</p><p>   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.</p><p>   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.</p><p>   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.</p><p>   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.</p><p>   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.  </p><p> (Reporting by Alistair Smout Editing by Bill Berkrot)</p><p>((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108796672","content_text":"LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and AstraZeneca Plc  are combined in a two-shot schedule.       The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.       The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks.    Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine.    It is expected more vaccines will be added to the trial when they are approved and rolled out.   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.   (Reporting by Alistair Smout Editing by Bill Berkrot)((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314102811,"gmtCreate":1612316052533,"gmtModify":1703760253591,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/314102811","repostId":"2108275853","repostType":2,"repost":{"id":"2108275853","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612313204,"share":"https://www.laohu8.com/m/news/2108275853?lang=&edition=full","pubTime":"2021-02-03 08:46","market":"us","language":"en","title":"PRESS DIGEST- Financial Times - Feb. 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2108275853","media":"Reuters","summary":"Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified","content":"<html><body><p>Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>   Headlines</p><p>   UK starts process to form post-Brexit state-aid watchdog </p><p>   Amazon's Jeff Bezos to step aside as chief executive this year </p><p>   Oxford/AstraZeneca study supports UK decision to delay second doses </p><p>   Steve Cohen's Point72 raises $1.5bn </p><p>   Overview</p><p>   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.</p><p>   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.</p><p>   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.</p><p>    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze.</p><p> (Compiled by Bengaluru newsroom)</p><p>((globalnewsmonitoring@thomsonreuters.com))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PRESS DIGEST- Financial Times - Feb. 3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPRESS DIGEST- Financial Times - Feb. 3\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-03 08:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>   Headlines</p><p>   UK starts process to form post-Brexit state-aid watchdog </p><p>   Amazon's Jeff Bezos to step aside as chief executive this year </p><p>   Oxford/AstraZeneca study supports UK decision to delay second doses </p><p>   Steve Cohen's Point72 raises $1.5bn </p><p>   Overview</p><p>   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.</p><p>   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.</p><p>   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.</p><p>    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze.</p><p> (Compiled by Bengaluru newsroom)</p><p>((globalnewsmonitoring@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","09086":"华夏纳指-U"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108275853","content_text":"Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.   Headlines   UK starts process to form post-Brexit state-aid watchdog    Amazon's Jeff Bezos to step aside as chief executive this year    Oxford/AstraZeneca study supports UK decision to delay second doses    Steve Cohen's Point72 raises $1.5bn    Overview   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze. (Compiled by Bengaluru newsroom)((globalnewsmonitoring@thomsonreuters.com))","news_type":1},"isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314106459,"gmtCreate":1612316032171,"gmtModify":1703760252561,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"赞！","listText":"赞！","text":"赞！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/314106459","repostId":"2108758903","repostType":2,"repost":{"id":"2108758903","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612314061,"share":"https://www.laohu8.com/m/news/2108758903?lang=&edition=full","pubTime":"2021-02-03 09:01","market":"us","language":"en","title":"New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2108758903","media":"Reuters","summary":"WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the","content":"<html><body><p>WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc</p><p>  and German's BioNTech   , the government said on Wednesday.</p><p>   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.” </p><p>   The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year. </p><p> (Reporting by Praveen Menon; editing by Jane Wardell)</p><p>((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>: ))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-03 09:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc</p><p>  and German's BioNTech   , the government said on Wednesday.</p><p>   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.” </p><p>   The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year. </p><p> (Reporting by Praveen Menon; editing by Jane Wardell)</p><p>((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>: ))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108758903","content_text":"WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc  and German's BioNTech   , the government said on Wednesday.   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.”    The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year.  (Reporting by Praveen Menon; editing by Jane Wardell)((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; Twitter: ))","news_type":1},"isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":315117446,"gmtCreate":1612221072485,"gmtModify":1703758926850,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/315117446","repostId":"2108820995","repostType":2,"repost":{"id":"2108820995","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612210544,"share":"https://www.laohu8.com/m/news/2108820995?lang=&edition=full","pubTime":"2021-02-02 04:15","market":"us","language":"en","title":"'Black Panther' director developing Wakanda TV series for Disney+","url":"https://stock-news.laohu8.com/highlight/detail?id=2108820995","media":"Reuters","summary":"LOS ANGELES, Feb 1 (Reuters) - \"Black Panther\" director Ryan Coogler is developing a streaming telev","content":"<html><body><p>LOS ANGELES, Feb 1 (Reuters) - \"Black Panther\" director Ryan Coogler is developing a streaming television series set in the movie's fictional kingdom of Wakanda, Walt Disney Co    said on Monday.</p><p>   The new series for the Disney+ streaming service will be created as part of a five-year television deal with Coogler's Proximity Media, Disney said in a statement.</p><p> (Reporting by Lisa Richwine; Editing by Leslie Adler)</p><p>((lisa.richwine@thomsonreuters.com; Follow me on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> @LARichwine; 1-424-434-7324; Reuters Messaging: lisa.richwine.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>'Black Panther' director developing Wakanda TV series for Disney+</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n'Black Panther' director developing Wakanda TV series for Disney+\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-02 04:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>LOS ANGELES, Feb 1 (Reuters) - \"Black Panther\" director Ryan Coogler is developing a streaming television series set in the movie's fictional kingdom of Wakanda, Walt Disney Co    said on Monday.</p><p>   The new series for the Disney+ streaming service will be created as part of a five-year television deal with Coogler's Proximity Media, Disney said in a statement.</p><p> (Reporting by Lisa Richwine; Editing by Leslie Adler)</p><p>((lisa.richwine@thomsonreuters.com; Follow me on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> @LARichwine; 1-424-434-7324; Reuters Messaging: lisa.richwine.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108820995","content_text":"LOS ANGELES, Feb 1 (Reuters) - \"Black Panther\" director Ryan Coogler is developing a streaming television series set in the movie's fictional kingdom of Wakanda, Walt Disney Co    said on Monday.   The new series for the Disney+ streaming service will be created as part of a five-year television deal with Coogler's Proximity Media, Disney said in a statement. (Reporting by Lisa Richwine; Editing by Leslie Adler)((lisa.richwine@thomsonreuters.com; Follow me on Twitter @LARichwine; 1-424-434-7324; Reuters Messaging: lisa.richwine.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":984,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":315117373,"gmtCreate":1612220822192,"gmtModify":1703758926159,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"[开心]&nbsp;","listText":"[开心]&nbsp;","text":"[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/315117373","repostId":"2108271505","repostType":4,"isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":382821194,"gmtCreate":1613432028718,"gmtModify":1634553724337,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"[开心]&nbsp;","listText":"[开心]&nbsp;","text":"[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":6,"repostSize":0,"link":"https://laohu8.com/post/382821194","repostId":"2111001462","repostType":2,"repost":{"id":"2111001462","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613408688,"share":"https://www.laohu8.com/m/news/2111001462?lang=&edition=full","pubTime":"2021-02-16 01:04","market":"us","language":"en","title":"Not enough data yet about vaccine effect on COVID-19 spread- UK PM Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2111001462","media":"Reuters","summary":"LONDON, Feb 15 (Reuters) - There is not yet enough data about how vaccines are affecting the spread ","content":"<html><body><p>LONDON, Feb 15 (Reuters) - There is not yet enough data about how vaccines are affecting the spread of COVID-19, British Prime Minister Boris Johnson said on Monday as he faces pressure from some of his own lawmakers who are keen to ease lockdown measures. </p><p>   \"Although the vaccination programme is going well, we still don't have enough data about the exact effectiveness of the vaccines in reducing the spread of infection,\" he told a news conference.</p><p> (Reporting by Guy Faulconbridge; writing by Costas Pitas; editing by William James)</p><p>((Costas.Pitas@thomsonreuters.com; 0207 513 4700; Reuters Messaging: costas.pitas.thomsonreuters@reuters.net and @Cpitas on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Not enough data yet about vaccine effect on COVID-19 spread- UK PM Johnson</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNot enough data yet about vaccine effect on COVID-19 spread- UK PM Johnson\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-16 01:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>LONDON, Feb 15 (Reuters) - There is not yet enough data about how vaccines are affecting the spread of COVID-19, British Prime Minister Boris Johnson said on Monday as he faces pressure from some of his own lawmakers who are keen to ease lockdown measures. </p><p>   \"Although the vaccination programme is going well, we still don't have enough data about the exact effectiveness of the vaccines in reducing the spread of infection,\" he told a news conference.</p><p> (Reporting by Guy Faulconbridge; writing by Costas Pitas; editing by William James)</p><p>((Costas.Pitas@thomsonreuters.com; 0207 513 4700; Reuters Messaging: costas.pitas.thomsonreuters@reuters.net and @Cpitas on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111001462","content_text":"LONDON, Feb 15 (Reuters) - There is not yet enough data about how vaccines are affecting the spread of COVID-19, British Prime Minister Boris Johnson said on Monday as he faces pressure from some of his own lawmakers who are keen to ease lockdown measures.    \"Although the vaccination programme is going well, we still don't have enough data about the exact effectiveness of the vaccines in reducing the spread of infection,\" he told a news conference. (Reporting by Guy Faulconbridge; writing by Costas Pitas; editing by William James)((Costas.Pitas@thomsonreuters.com; 0207 513 4700; Reuters Messaging: costas.pitas.thomsonreuters@reuters.net and @Cpitas on Twitter))","news_type":1},"isVote":1,"tweetType":1,"viewCount":786,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":384166185,"gmtCreate":1613627254947,"gmtModify":1634552877842,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Yay!!!","listText":"Yay!!!","text":"Yay!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/384166185","repostId":"2112863205","repostType":2,"repost":{"id":"2112863205","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613625832,"share":"https://www.laohu8.com/m/news/2112863205?lang=&edition=full","pubTime":"2021-02-18 13:23","market":"us","language":"en","title":"Tesla reduces price of base variant of Model 3 and Model Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2112863205","media":"Reuters","summary":"Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.\n\n\nTesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.","content":"<p>Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.</p>\n<p>Tesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla reduces price of base variant of Model 3 and Model Y</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla reduces price of base variant of Model 3 and Model Y\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-18 13:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.</p>\n<p>Tesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2112863205","content_text":"Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.\nTesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.","news_type":1},"isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188565115,"gmtCreate":1623455571137,"gmtModify":1634033057017,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Let’s go","listText":"Let’s go","text":"Let’s go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/188565115","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://www.laohu8.com/m/news/2142204074?lang=&edition=full","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","QQQ":"纳指100ETF",".DJI":"道琼斯","DOG":"道指反向ETF",".IXIC":"NASDAQ Composite","UPRO":"三倍做多标普500ETF",".SPX":"S&P 500 Index","UDOW":"道指三倍做多ETF-ProShares","OEX":"标普100","QID":"纳指两倍做空ETF","SH":"标普500反向ETF","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF","DJX":"1/100道琼斯","OEF":"标普100指数ETF-iShares","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","QLD":"纳指两倍做多ETF","DXD":"道指两倍做空ETF","PSQ":"纳指反向ETF","SDOW":"道指三倍做空ETF-ProShares","DDM":"道指两倍做多ETF","SDS":"两倍做空标普500ETF","TQQQ":"纳指三倍做多ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":385784843,"gmtCreate":1613576311482,"gmtModify":1634553075085,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"[财迷]&nbsp;","listText":"[财迷]&nbsp;","text":"[财迷]","images":[{"img":"https://static.tigerbbs.com/9faf84e9f534c3dfd62f018bc08dc86d","width":"1125","height":"3035"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/385784843","isVote":1,"tweetType":1,"viewCount":752,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":312354759,"gmtCreate":1612050217671,"gmtModify":1703757513455,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Power of social media","listText":"Power of social media","text":"Power of social media","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/312354759","repostId":"2107223679","repostType":2,"repost":{"id":"2107223679","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1612044660,"share":"https://www.laohu8.com/m/news/2107223679?lang=&edition=full","pubTime":"2021-01-31 06:11","market":"us","language":"en","title":"How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2107223679","media":"Dow Jones","summary":"MW UPDATE: How you could lose everything by short-selling stocks, whether it's betting against GameS","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla\n</p>\n<p>\n  By Philip van Doorn \n</p>\n<p>\n  GameStop short-sellers are blowing up professional investors' funds. But the story is far different for bets against Tesla and other large-cap stocks. \n</p>\n<p>\n  The wild ride for GameStop Corp.'s stock illustrates the power of social media to force short-sellers -- even professional investors -- to give up on their positions and book heavy losses. But talk of individual investors \"breaking\" the mechanics of the stock market may be premature. \n</p>\n<p>\n  Among the S&amp;P Composite 1500, GameStop is the  most heavily shorted stock as a percentage of shares available for sale, according to  FactSet, which updates the numbers twice a month. The most heavily shorted stock in dollars is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>. \n</p>\n<p>\n  Tesla and other large companies, including Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> and Apple Inc. <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, have tens of billions of dollars in short sales against their stocks. Those bets center around hedge funds and other professional investors making much bigger wagers than the ones against GameStop. \n</p>\n<p>\n  \"I have never see anybody rush the capital markets like they did [into GameStop's shares], and it could not have occurred without social media. The public has gotten so much more involved in individual stocks that they are overwhelming the professionals right now, in these small- and mid-cap stocks. Not in Tesla,\" said Brad Lamensdorf, CEO of ActiveAlts in Westport, Conn., who runs long and short investment strategies. \n</p>\n<p>\n  Regardless, GameStop's action illustrates, once again, why non-professionals shouldn't short-sell stocks. \n</p>\n<p>\n  Take a look at the <a href=\"https://laohu8.com/S/AONE\">one</a>-year chart  for GameStop's stock through Jan. 25: \n</p>\n<p>\n  That's a rocket ride, as investors who connected through Reddit poured money into the shares, pushing the price up,  which forced investors with short positions to cover, which pushed up the shares even higher, despite a lack of any recent good financial news from the company , as Wallace Witkowski explained. \n</p>\n<p>\n  Short-selling is when an investor borrows shares and immediately sells them, hoping he or she can buy them back later at a lower price, return them to the lender and pocket the difference. \n</p>\n<p>\n  What makes shorting stocks best left to professionals is the potential for unlimited losses. In contrast, if you buy shares of a company (take a \"long\" position) and the stock falls, your potential loss is the amount of your investment. It can be wiped out if the company goes bankrupt. \n</p>\n<p>\n  But if you short a stock, what if it goes up and keeps going up? Your loss potential goes to infinity. At some point you will probably give up and \"cover\" your short position by buying the shares to return them to the lender, and take the loss. If you borrow shares and sell them for $10, and then cover at $20, you just lost $10 a share. If a stock you have shorted rises, your broker eventually will demand more collateral -- cash set aside to protect the broker from potential losses as your loss position increases in size. \n</p>\n<p>\n  So a short squeeze is a scramble among investors with short positions to buy shares and cover as quickly as possible. It can create a feeding frenzy and a temporary spike in the share price, as we have seen for GameStop. \n</p>\n<p>\n  On Monday, while discussing GameStop, Jim Cramer said on CNBC  that \"[t]he mechanics of the market are breaking down. It's arguable that these people are all <a href=\"https://laohu8.com/S/AONE.U\">one</a> group.\" \n</p>\n<p>\n  Starting with the S&amp;P Composite 1500 Index (made up of the S&amp;P 500 , the S&amp;P 400 Mid Cap Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small-Cap 600 Index ), here are the 20 stocks with the highest percentages of shares sold short against the total number of shares available for trading: \n</p>\n<p>\n  Scroll the table to see all the data. \n</p>\n<p>\n  The short percentages supplied by FactSet are updated twice a month, based on the most recently available data for shares sold short and the number of shares outstanding and available for trading as of the previous month-end. \n</p>\n<p>\n  Lamensdorf, who co-manages the AdvisorShares <a href=\"https://laohu8.com/S/HDGE\">Ranger Equity Bear ETF</a> (HDGE), argues that any short percentage \"over 30% to 40% is outrageously high.\" Participating in a trade that is so aggressive is very risky because the chance of a short squeeze is so much higher, he said during an interview. \n</p>\n<p>\n  Read:As day traders make wild options bets in search of 'lottery-like payoffs' in the stock market, some fear history is repeating itself  \n</p>\n<p>\n  HDGE is designed to be used by professional investors as a hedging tool. The ETF takes short positions in companies its managers believe exhibit low earnings quality or \"aggressive accounting\" that may \"mask operational deterioration.\" \n</p>\n<p>\n  Lamensdorf stressed that in a bull market, a short-only fund is \"a very lonely place,\" and that it is meant to be used to help investors create their own long/short strategies. \n</p>\n<p>\n  Professional money managers' long/short strategies help explain why a company such as CleanSpark Inc. <a href=\"https://laohu8.com/S/CLSK\">$(CLSK)$</a>, whose shares have risen from about $10 in late November to $25 recently, still has 10% of its shares sold short. \n</p>\n<p>\n  \"Some of the quantitative investors are levered two-to-one, and they are long/short similar companies, and are just trying to play the spread between the two. They do not care if they are squeezed with some, because they have something on the other side appreciating at a similar rate,\" according to Lamensdorf. \n</p>\n<p>\n  While discussing the GameStop short squeeze, Lamensdorf said this sort of action -- individual investors using social media to greatly affect a stock's movement -- isn't happening with large companies. Tesla Inc. (TSLA) provides an astounding example. \n</p>\n<p>\n  When asked how it was possible for more  than 100% of GameStop's shares to be sold short, Lamensdorf said that there are places where people can have \"naked\" short positions -- those that didn't involve actually borrowing the shares to short them. \n</p>\n<p>\n  \"It is illegal, in general, to short a stock without borrowing,\" he said, \"but sometimes a broker is not as careful as it need to be.\" \n</p>\n<p>\n  In the S&amp;P Composite 1500, here are the 20 companies with the highest amount of dollars' worth of shares sold short: \n</p>\n<p>\n  So 8% of Tesla's float is sold short, but that is $66.7 billion. \n</p>\n<p>\n  \"That's not Robinhood, dude!\" Lamensdorf said -- emphasizing that for the largest companies, the short action is controlled by hedge funds and other professional investors. \n</p>\n<p>\n  It is notable that GameStop is on both lists -- it shows how extreme the situation is for that stock, at least until FactSet's data catches up with all the covered short positions. \n</p>\n<p>\n  Take a look at the second company on the second table: Amazon has only 1% of its float sold short, but that adds up to $12.7 billion. Next is Apple with a significant 5% short, for $12.5 billion. Other companies on the list that may surprise you include Microsoft Corp. <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc. (FB) and Nvidia Corp. <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, but again, these companies have relatively small percentages of short-sales but large market capitalizations. \n</p>\n<p>\n  Lamensdorf  is CEO of ActiveAlts, through which he and colleagues run  a \"momentum\" strategy that focuses on stocks of heavily shorted companies. \n</p>\n<p>\n  An example of a heavily shorted stock that has been very profitable for Lamensdorf is BlackBerry Ltd. (BB.T). Take a look at the one-year chart: \n</p>\n<p>\n  Shares of BlackBerry began to fly up after the company announced a multiyear deal to provide software for Amazon Web Services . Lamensdorf said that BlackBerry had already been \"a core position of ours,\" because of his confidence that the company, under the leadership of CEO John Chen, would continue to enter new contracts with companies developing technology for autonomous vehicles and otherwise connected vehicles. \n</p>\n<p>\n  BlackBerry always had a reputation for excellent network security. That wasn't enough to save its smartphone business from the iPhone and Android phones, but there is a growing need for what BlackBerry offers. \n</p>\n<p>\n  The action for BlackBerry's stock continues to be heated. The shares flew up 28% on Jan. 25, and on the same day, the company released a statement saying it was \"not awar  to develop autonomous driving technology. \n</p>\n<p>\n  According to FactSet, 7.1% of BlackBerry's shares are still sold short. On a market cap that has now reached $10.1 billion, that's more than $700 million in short bets against the company. \n</p>\n<p>\n  \"You are talking about short-sellers down $1.4 billion,\" Lamensdorf said. \n</p>\n<p>\n  -Philip van Doorn; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  January 30, 2021 17:11 ET (22:11 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-01-31 06:11</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla\n</p>\n<p>\n  By Philip van Doorn \n</p>\n<p>\n  GameStop short-sellers are blowing up professional investors' funds. But the story is far different for bets against Tesla and other large-cap stocks. \n</p>\n<p>\n  The wild ride for GameStop Corp.'s stock illustrates the power of social media to force short-sellers -- even professional investors -- to give up on their positions and book heavy losses. But talk of individual investors \"breaking\" the mechanics of the stock market may be premature. \n</p>\n<p>\n  Among the S&amp;P Composite 1500, GameStop is the  most heavily shorted stock as a percentage of shares available for sale, according to  FactSet, which updates the numbers twice a month. The most heavily shorted stock in dollars is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>. \n</p>\n<p>\n  Tesla and other large companies, including Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> and Apple Inc. <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, have tens of billions of dollars in short sales against their stocks. Those bets center around hedge funds and other professional investors making much bigger wagers than the ones against GameStop. \n</p>\n<p>\n  \"I have never see anybody rush the capital markets like they did [into GameStop's shares], and it could not have occurred without social media. The public has gotten so much more involved in individual stocks that they are overwhelming the professionals right now, in these small- and mid-cap stocks. Not in Tesla,\" said Brad Lamensdorf, CEO of ActiveAlts in Westport, Conn., who runs long and short investment strategies. \n</p>\n<p>\n  Regardless, GameStop's action illustrates, once again, why non-professionals shouldn't short-sell stocks. \n</p>\n<p>\n  Take a look at the <a href=\"https://laohu8.com/S/AONE\">one</a>-year chart  for GameStop's stock through Jan. 25: \n</p>\n<p>\n  That's a rocket ride, as investors who connected through Reddit poured money into the shares, pushing the price up,  which forced investors with short positions to cover, which pushed up the shares even higher, despite a lack of any recent good financial news from the company , as Wallace Witkowski explained. \n</p>\n<p>\n  Short-selling is when an investor borrows shares and immediately sells them, hoping he or she can buy them back later at a lower price, return them to the lender and pocket the difference. \n</p>\n<p>\n  What makes shorting stocks best left to professionals is the potential for unlimited losses. In contrast, if you buy shares of a company (take a \"long\" position) and the stock falls, your potential loss is the amount of your investment. It can be wiped out if the company goes bankrupt. \n</p>\n<p>\n  But if you short a stock, what if it goes up and keeps going up? Your loss potential goes to infinity. At some point you will probably give up and \"cover\" your short position by buying the shares to return them to the lender, and take the loss. If you borrow shares and sell them for $10, and then cover at $20, you just lost $10 a share. If a stock you have shorted rises, your broker eventually will demand more collateral -- cash set aside to protect the broker from potential losses as your loss position increases in size. \n</p>\n<p>\n  So a short squeeze is a scramble among investors with short positions to buy shares and cover as quickly as possible. It can create a feeding frenzy and a temporary spike in the share price, as we have seen for GameStop. \n</p>\n<p>\n  On Monday, while discussing GameStop, Jim Cramer said on CNBC  that \"[t]he mechanics of the market are breaking down. It's arguable that these people are all <a href=\"https://laohu8.com/S/AONE.U\">one</a> group.\" \n</p>\n<p>\n  Starting with the S&amp;P Composite 1500 Index (made up of the S&amp;P 500 , the S&amp;P 400 Mid Cap Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small-Cap 600 Index ), here are the 20 stocks with the highest percentages of shares sold short against the total number of shares available for trading: \n</p>\n<p>\n  Scroll the table to see all the data. \n</p>\n<p>\n  The short percentages supplied by FactSet are updated twice a month, based on the most recently available data for shares sold short and the number of shares outstanding and available for trading as of the previous month-end. \n</p>\n<p>\n  Lamensdorf, who co-manages the AdvisorShares <a href=\"https://laohu8.com/S/HDGE\">Ranger Equity Bear ETF</a> (HDGE), argues that any short percentage \"over 30% to 40% is outrageously high.\" Participating in a trade that is so aggressive is very risky because the chance of a short squeeze is so much higher, he said during an interview. \n</p>\n<p>\n  Read:As day traders make wild options bets in search of 'lottery-like payoffs' in the stock market, some fear history is repeating itself  \n</p>\n<p>\n  HDGE is designed to be used by professional investors as a hedging tool. The ETF takes short positions in companies its managers believe exhibit low earnings quality or \"aggressive accounting\" that may \"mask operational deterioration.\" \n</p>\n<p>\n  Lamensdorf stressed that in a bull market, a short-only fund is \"a very lonely place,\" and that it is meant to be used to help investors create their own long/short strategies. \n</p>\n<p>\n  Professional money managers' long/short strategies help explain why a company such as CleanSpark Inc. <a href=\"https://laohu8.com/S/CLSK\">$(CLSK)$</a>, whose shares have risen from about $10 in late November to $25 recently, still has 10% of its shares sold short. \n</p>\n<p>\n  \"Some of the quantitative investors are levered two-to-one, and they are long/short similar companies, and are just trying to play the spread between the two. They do not care if they are squeezed with some, because they have something on the other side appreciating at a similar rate,\" according to Lamensdorf. \n</p>\n<p>\n  While discussing the GameStop short squeeze, Lamensdorf said this sort of action -- individual investors using social media to greatly affect a stock's movement -- isn't happening with large companies. Tesla Inc. (TSLA) provides an astounding example. \n</p>\n<p>\n  When asked how it was possible for more  than 100% of GameStop's shares to be sold short, Lamensdorf said that there are places where people can have \"naked\" short positions -- those that didn't involve actually borrowing the shares to short them. \n</p>\n<p>\n  \"It is illegal, in general, to short a stock without borrowing,\" he said, \"but sometimes a broker is not as careful as it need to be.\" \n</p>\n<p>\n  In the S&amp;P Composite 1500, here are the 20 companies with the highest amount of dollars' worth of shares sold short: \n</p>\n<p>\n  So 8% of Tesla's float is sold short, but that is $66.7 billion. \n</p>\n<p>\n  \"That's not Robinhood, dude!\" Lamensdorf said -- emphasizing that for the largest companies, the short action is controlled by hedge funds and other professional investors. \n</p>\n<p>\n  It is notable that GameStop is on both lists -- it shows how extreme the situation is for that stock, at least until FactSet's data catches up with all the covered short positions. \n</p>\n<p>\n  Take a look at the second company on the second table: Amazon has only 1% of its float sold short, but that adds up to $12.7 billion. Next is Apple with a significant 5% short, for $12.5 billion. Other companies on the list that may surprise you include Microsoft Corp. <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc. (FB) and Nvidia Corp. <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, but again, these companies have relatively small percentages of short-sales but large market capitalizations. \n</p>\n<p>\n  Lamensdorf  is CEO of ActiveAlts, through which he and colleagues run  a \"momentum\" strategy that focuses on stocks of heavily shorted companies. \n</p>\n<p>\n  An example of a heavily shorted stock that has been very profitable for Lamensdorf is BlackBerry Ltd. (BB.T). Take a look at the one-year chart: \n</p>\n<p>\n  Shares of BlackBerry began to fly up after the company announced a multiyear deal to provide software for Amazon Web Services . Lamensdorf said that BlackBerry had already been \"a core position of ours,\" because of his confidence that the company, under the leadership of CEO John Chen, would continue to enter new contracts with companies developing technology for autonomous vehicles and otherwise connected vehicles. \n</p>\n<p>\n  BlackBerry always had a reputation for excellent network security. That wasn't enough to save its smartphone business from the iPhone and Android phones, but there is a growing need for what BlackBerry offers. \n</p>\n<p>\n  The action for BlackBerry's stock continues to be heated. The shares flew up 28% on Jan. 25, and on the same day, the company released a statement saying it was \"not awar  to develop autonomous driving technology. \n</p>\n<p>\n  According to FactSet, 7.1% of BlackBerry's shares are still sold short. On a market cap that has now reached $10.1 billion, that's more than $700 million in short bets against the company. \n</p>\n<p>\n  \"You are talking about short-sellers down $1.4 billion,\" Lamensdorf said. \n</p>\n<p>\n  -Philip van Doorn; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  January 30, 2021 17:11 ET (22:11 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BB":"黑莓","GME":"游戏驿站","AMZN":"亚马逊","AAPL":"苹果","TSLA":"特斯拉"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2107223679","content_text":"MW UPDATE: How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla\n\n\n  By Philip van Doorn \n\n\n  GameStop short-sellers are blowing up professional investors' funds. But the story is far different for bets against Tesla and other large-cap stocks. \n\n\n  The wild ride for GameStop Corp.'s stock illustrates the power of social media to force short-sellers -- even professional investors -- to give up on their positions and book heavy losses. But talk of individual investors \"breaking\" the mechanics of the stock market may be premature. \n\n\n  Among the S&P Composite 1500, GameStop is the  most heavily shorted stock as a percentage of shares available for sale, according to  FactSet, which updates the numbers twice a month. The most heavily shorted stock in dollars is Tesla Inc. $(TSLA)$. \n\n\n  Tesla and other large companies, including Amazon.com Inc. $(AMZN)$ and Apple Inc. $(AAPL)$, have tens of billions of dollars in short sales against their stocks. Those bets center around hedge funds and other professional investors making much bigger wagers than the ones against GameStop. \n\n\n  \"I have never see anybody rush the capital markets like they did [into GameStop's shares], and it could not have occurred without social media. The public has gotten so much more involved in individual stocks that they are overwhelming the professionals right now, in these small- and mid-cap stocks. Not in Tesla,\" said Brad Lamensdorf, CEO of ActiveAlts in Westport, Conn., who runs long and short investment strategies. \n\n\n  Regardless, GameStop's action illustrates, once again, why non-professionals shouldn't short-sell stocks. \n\n\n  Take a look at the one-year chart  for GameStop's stock through Jan. 25: \n\n\n  That's a rocket ride, as investors who connected through Reddit poured money into the shares, pushing the price up,  which forced investors with short positions to cover, which pushed up the shares even higher, despite a lack of any recent good financial news from the company , as Wallace Witkowski explained. \n\n\n  Short-selling is when an investor borrows shares and immediately sells them, hoping he or she can buy them back later at a lower price, return them to the lender and pocket the difference. \n\n\n  What makes shorting stocks best left to professionals is the potential for unlimited losses. In contrast, if you buy shares of a company (take a \"long\" position) and the stock falls, your potential loss is the amount of your investment. It can be wiped out if the company goes bankrupt. \n\n\n  But if you short a stock, what if it goes up and keeps going up? Your loss potential goes to infinity. At some point you will probably give up and \"cover\" your short position by buying the shares to return them to the lender, and take the loss. If you borrow shares and sell them for $10, and then cover at $20, you just lost $10 a share. If a stock you have shorted rises, your broker eventually will demand more collateral -- cash set aside to protect the broker from potential losses as your loss position increases in size. \n\n\n  So a short squeeze is a scramble among investors with short positions to buy shares and cover as quickly as possible. It can create a feeding frenzy and a temporary spike in the share price, as we have seen for GameStop. \n\n\n  On Monday, while discussing GameStop, Jim Cramer said on CNBC  that \"[t]he mechanics of the market are breaking down. It's arguable that these people are all one group.\" \n\n\n  Starting with the S&P Composite 1500 Index (made up of the S&P 500 , the S&P 400 Mid Cap Index $(MID)$ and the S&P Small-Cap 600 Index ), here are the 20 stocks with the highest percentages of shares sold short against the total number of shares available for trading: \n\n\n  Scroll the table to see all the data. \n\n\n  The short percentages supplied by FactSet are updated twice a month, based on the most recently available data for shares sold short and the number of shares outstanding and available for trading as of the previous month-end. \n\n\n  Lamensdorf, who co-manages the AdvisorShares Ranger Equity Bear ETF (HDGE), argues that any short percentage \"over 30% to 40% is outrageously high.\" Participating in a trade that is so aggressive is very risky because the chance of a short squeeze is so much higher, he said during an interview. \n\n\n  Read:As day traders make wild options bets in search of 'lottery-like payoffs' in the stock market, some fear history is repeating itself  \n\n\n  HDGE is designed to be used by professional investors as a hedging tool. The ETF takes short positions in companies its managers believe exhibit low earnings quality or \"aggressive accounting\" that may \"mask operational deterioration.\" \n\n\n  Lamensdorf stressed that in a bull market, a short-only fund is \"a very lonely place,\" and that it is meant to be used to help investors create their own long/short strategies. \n\n\n  Professional money managers' long/short strategies help explain why a company such as CleanSpark Inc. $(CLSK)$, whose shares have risen from about $10 in late November to $25 recently, still has 10% of its shares sold short. \n\n\n  \"Some of the quantitative investors are levered two-to-one, and they are long/short similar companies, and are just trying to play the spread between the two. They do not care if they are squeezed with some, because they have something on the other side appreciating at a similar rate,\" according to Lamensdorf. \n\n\n  While discussing the GameStop short squeeze, Lamensdorf said this sort of action -- individual investors using social media to greatly affect a stock's movement -- isn't happening with large companies. Tesla Inc. (TSLA) provides an astounding example. \n\n\n  When asked how it was possible for more  than 100% of GameStop's shares to be sold short, Lamensdorf said that there are places where people can have \"naked\" short positions -- those that didn't involve actually borrowing the shares to short them. \n\n\n  \"It is illegal, in general, to short a stock without borrowing,\" he said, \"but sometimes a broker is not as careful as it need to be.\" \n\n\n  In the S&P Composite 1500, here are the 20 companies with the highest amount of dollars' worth of shares sold short: \n\n\n  So 8% of Tesla's float is sold short, but that is $66.7 billion. \n\n\n  \"That's not Robinhood, dude!\" Lamensdorf said -- emphasizing that for the largest companies, the short action is controlled by hedge funds and other professional investors. \n\n\n  It is notable that GameStop is on both lists -- it shows how extreme the situation is for that stock, at least until FactSet's data catches up with all the covered short positions. \n\n\n  Take a look at the second company on the second table: Amazon has only 1% of its float sold short, but that adds up to $12.7 billion. Next is Apple with a significant 5% short, for $12.5 billion. Other companies on the list that may surprise you include Microsoft Corp. $(MSFT)$, Facebook Inc. (FB) and Nvidia Corp. $(NVDA)$, but again, these companies have relatively small percentages of short-sales but large market capitalizations. \n\n\n  Lamensdorf  is CEO of ActiveAlts, through which he and colleagues run  a \"momentum\" strategy that focuses on stocks of heavily shorted companies. \n\n\n  An example of a heavily shorted stock that has been very profitable for Lamensdorf is BlackBerry Ltd. (BB.T). Take a look at the one-year chart: \n\n\n  Shares of BlackBerry began to fly up after the company announced a multiyear deal to provide software for Amazon Web Services . Lamensdorf said that BlackBerry had already been \"a core position of ours,\" because of his confidence that the company, under the leadership of CEO John Chen, would continue to enter new contracts with companies developing technology for autonomous vehicles and otherwise connected vehicles. \n\n\n  BlackBerry always had a reputation for excellent network security. That wasn't enough to save its smartphone business from the iPhone and Android phones, but there is a growing need for what BlackBerry offers. \n\n\n  The action for BlackBerry's stock continues to be heated. The shares flew up 28% on Jan. 25, and on the same day, the company released a statement saying it was \"not awar  to develop autonomous driving technology. \n\n\n  According to FactSet, 7.1% of BlackBerry's shares are still sold short. On a market cap that has now reached $10.1 billion, that's more than $700 million in short bets against the company. \n\n\n  \"You are talking about short-sellers down $1.4 billion,\" Lamensdorf said. \n\n\n  -Philip van Doorn; 415-439-6400; AskNewswires@dowjones.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  January 30, 2021 17:11 ET (22:11 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":152,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386076859,"gmtCreate":1613121547571,"gmtModify":1634554454410,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/386076859","repostId":"2110026963","repostType":2,"repost":{"id":"2110026963","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1613109422,"share":"https://www.laohu8.com/m/news/2110026963?lang=&edition=full","pubTime":"2021-02-12 13:57","market":"us","language":"en","title":"Here's the formula for spotting genuinely undervalued companies, claims this investment house","url":"https://stock-news.laohu8.com/highlight/detail?id=2110026963","media":"Dow Jones","summary":"The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis. For most of 2020, investors poured money into names like online retailer Amazon $$, electric-car maker Tesla $$, and e-commerce platform Shopify -- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.But when news broke in early November 2020 that drug company Pfizer $$ and its partner BioNTech $$ had developed an effective vaccine against COVID-19, something pro","content":"<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's the formula for spotting genuinely undervalued companies, claims this investment house</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's the formula for spotting genuinely undervalued companies, claims this investment house\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-02-12 13:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/15e20574f8fb568333181d61bb200086","relate_stocks":{"PFE":"辉瑞","AMZN":"亚马逊","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2110026963","content_text":"MW Here's the formula for spotting genuinely undervalued companies, claims this investment house\nThe growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis\nFor most of 2020, investors poured money into names like online retailer Amazon $(AMZN)$, electric-car maker Tesla $(TSLA)$, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.\nBut when news broke in early November 2020 that drug company Pfizer $(PFE)$ and its partner BioNTech $(BNTX)$ had developed an effective vaccine against COVID-19, something profound happened in financial markets.\nInvestors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.\nThis rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.\nAnd it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.\nThe apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.\n\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.\n\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"\nAnalysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.\nThe value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.\nIn reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.\nStocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.\nTo have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.","news_type":1},"isVote":1,"tweetType":1,"viewCount":497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317022586,"gmtCreate":1612400076245,"gmtModify":1703761298065,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Another big player","listText":"Another big player","text":"Another big player","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/317022586","repostId":"2108795093","repostType":2,"repost":{"id":"2108795093","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1612394820,"share":"https://www.laohu8.com/m/news/2108795093?lang=&edition=full","pubTime":"2021-02-04 07:27","market":"us","language":"en","title":"Apple may build a fully autonomous electric car with Hyundai-Kia: report","url":"https://stock-news.laohu8.com/highlight/detail?id=2108795093","media":"Dow Jones","summary":"Apple Inc. is close to a deal with Hyundai-Kia to make an Apple-branded autonomous electric vehicle at a Kia plant in Georgia, CNBC reported late Wednesday, citing \"multiple\" sources who briefed CNBC on the plan.The so-called \"Apple car\" is being developed by a team at Apple  and would go into production in 2024, although that date could be pushed back, CNBC said.South Korean media reported earlier Wednesday that the Korean auto maker had received a $3.6 billion investment from Apple as part of ","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: Apple may build a fully autonomous electric car with Hyundai-Kia: report\n</p>\n<p>\n  By Claudia Assis \n</p>\n<p>\n  Apple Inc. is close to a deal with Hyundai-Kia to make an Apple-branded autonomous electric vehicle at a Kia plant in Georgia, CNBC reported late Wednesday, citing \"multiple\" sources who briefed CNBC on the plan. \n</p>\n<p>\n  The so-called \"Apple car\" is being developed by a team at Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a> and would go into production in 2024, although that date could be pushed back, CNBC said.   \n</p>\n<p>\n  No firm agreement has been reached between the companies, and Apple could opt to partner with another auto maker separately or in addition to working with Hyundai , CNBC said. \n</p>\n<p>\n  South Korean media reported earlier Wednesday that the Korean auto maker had received a $3.6 billion investment from Apple as part of a collaboration to make electric vehicles. Hyundai owns about a third of Kia  stock. \n</p>\n<p>\n  -Claudia Assis; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 03, 2021 18:27 ET (23:27 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple may build a fully autonomous electric car with Hyundai-Kia: report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple may build a fully autonomous electric car with Hyundai-Kia: report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-02-04 07:27</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: Apple may build a fully autonomous electric car with Hyundai-Kia: report\n</p>\n<p>\n  By Claudia Assis \n</p>\n<p>\n  Apple Inc. is close to a deal with Hyundai-Kia to make an Apple-branded autonomous electric vehicle at a Kia plant in Georgia, CNBC reported late Wednesday, citing \"multiple\" sources who briefed CNBC on the plan. \n</p>\n<p>\n  The so-called \"Apple car\" is being developed by a team at Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a> and would go into production in 2024, although that date could be pushed back, CNBC said.   \n</p>\n<p>\n  No firm agreement has been reached between the companies, and Apple could opt to partner with another auto maker separately or in addition to working with Hyundai , CNBC said. \n</p>\n<p>\n  South Korean media reported earlier Wednesday that the Korean auto maker had received a $3.6 billion investment from Apple as part of a collaboration to make electric vehicles. Hyundai owns about a third of Kia  stock. \n</p>\n<p>\n  -Claudia Assis; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  February 03, 2021 18:27 ET (23:27 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","03086":"华夏纳指","09086":"华夏纳指-U","HYMLY":"Hyundai Motor Co., Ltd."},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108795093","content_text":"MW UPDATE: Apple may build a fully autonomous electric car with Hyundai-Kia: report\n\n\n  By Claudia Assis \n\n\n  Apple Inc. is close to a deal with Hyundai-Kia to make an Apple-branded autonomous electric vehicle at a Kia plant in Georgia, CNBC reported late Wednesday, citing \"multiple\" sources who briefed CNBC on the plan. \n\n\n  The so-called \"Apple car\" is being developed by a team at Apple $(AAPL)$ and would go into production in 2024, although that date could be pushed back, CNBC said.   \n\n\n  No firm agreement has been reached between the companies, and Apple could opt to partner with another auto maker separately or in addition to working with Hyundai , CNBC said. \n\n\n  South Korean media reported earlier Wednesday that the Korean auto maker had received a $3.6 billion investment from Apple as part of a collaboration to make electric vehicles. Hyundai owns about a third of Kia  stock. \n\n\n  -Claudia Assis; 415-439-6400; AskNewswires@dowjones.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  February 03, 2021 18:27 ET (23:27 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":940,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":315117373,"gmtCreate":1612220822192,"gmtModify":1703758926159,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"[开心]&nbsp;","listText":"[开心]&nbsp;","text":"[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/315117373","repostId":"2108271505","repostType":4,"isVote":1,"tweetType":1,"viewCount":503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":386469204,"gmtCreate":1613258317708,"gmtModify":1634554099655,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386469204","repostId":"2111807728","repostType":2,"repost":{"id":"2111807728","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613256424,"share":"https://www.laohu8.com/m/news/2111807728?lang=&edition=full","pubTime":"2021-02-14 06:47","market":"us","language":"en","title":"Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2111807728","media":"Reuters","summary":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Transla","content":"<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-14 06:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TBIO":"TELESIS BIO","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111807728","content_text":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Translate Bio  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.   In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.     \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.   The CEO gave no other details. Officials at Sanofi were not available for comment.   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.     To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.     Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly. (Reporting by Matthias Blamont; Editing by Dominique Vidalon)((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))","news_type":1},"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386631333,"gmtCreate":1613168819622,"gmtModify":1634554296588,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386631333","repostId":"2111071977","repostType":2,"isVote":1,"tweetType":1,"viewCount":354,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389370655,"gmtCreate":1612702142177,"gmtModify":1703764372453,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389370655","repostId":"2109704729","repostType":2,"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380418956,"gmtCreate":1612573153275,"gmtModify":1703763743360,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"[呆住]&nbsp;","listText":"[呆住]&nbsp;","text":"[呆住]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/380418956","repostId":"2109777511","repostType":2,"repost":{"id":"2109777511","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612561140,"share":"https://www.laohu8.com/m/news/2109777511?lang=&edition=full","pubTime":"2021-02-06 05:39","market":"fut","language":"en","title":"BUZZ-U.S. stocks weekly: Gaming more aid","url":"https://stock-news.laohu8.com/highlight/detail?id=2109777511","media":"Reuters","summary":"** S&P 500    jumps 4.6%, enjoys best week since U.S. elections as investors bet on more government ","content":"<html><body><p>** S&amp;P 500    jumps 4.6%, enjoys best week since U.S. elections as investors bet on more government aid to bolster economy   </p><p>   ** That said, the SPX may have tired legs  </p><p>   ** This as the Dow    faces a rough ceiling  </p><p>   ** Indeed, it was 5000 points, and a cloud of dust</p><p>, though the Nasdaq    may have a crack under the surface  </p><p>   ** But by Fri, the Dow was swinging for its highs</p><p>   ** Every sector hits paydirt: energy and communication services are the MVPs</p><p>   ** Energy    surges 8.3%. Oil cos rise as crude hits 1-yr high on growth hopes, OPEC+ supply cuts  . Exxon</p><p>  gains as Wall Street sees co moving in right direction</p><p>, and reportedly had discussed merger with Chevron</p><p>  in early 2020  </p><p>   ** Communication services    rally 7.3%. Alphabet</p><p>  best in sector, up 14%, as Google search still king, but Cloud and YouTube strong supporting cast  </p><p>   ** Consumer Discretionary    up 6%. Amazon.com</p><p>  founder Bezos to give reins to cloud boss Jassy as sales rocket past $100 bln  </p><p>   ** Tech    lifts 4.9%. <a href=\"https://laohu8.com/S/PYPL\">PayPal</a>    leaps 15% on upbeat Q4 results as pandemic-driven shift to online shopping sends payment volumes surging  . But Qualcomm</p><p>  falls after sales miss on chip supply constraints</p><p>   ** Meanwhile, the GameStop    roller coaster continues</p><p>  , and when it comes to Super Bowl LV, will the market score, or fumble?   </p><p>   ** SPX performance YTD:    </p><p>(Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)</p><p>((lance.tupper.tr.com@reuters.net lance.tupper@tr.com terence.gabriel.tr.com@reuters.net terence.gabriel@tr.com))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-U.S. stocks weekly: Gaming more aid</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-U.S. stocks weekly: Gaming more aid\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-06 05:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>** S&amp;P 500    jumps 4.6%, enjoys best week since U.S. elections as investors bet on more government aid to bolster economy   </p><p>   ** That said, the SPX may have tired legs  </p><p>   ** This as the Dow    faces a rough ceiling  </p><p>   ** Indeed, it was 5000 points, and a cloud of dust</p><p>, though the Nasdaq    may have a crack under the surface  </p><p>   ** But by Fri, the Dow was swinging for its highs</p><p>   ** Every sector hits paydirt: energy and communication services are the MVPs</p><p>   ** Energy    surges 8.3%. Oil cos rise as crude hits 1-yr high on growth hopes, OPEC+ supply cuts  . Exxon</p><p>  gains as Wall Street sees co moving in right direction</p><p>, and reportedly had discussed merger with Chevron</p><p>  in early 2020  </p><p>   ** Communication services    rally 7.3%. Alphabet</p><p>  best in sector, up 14%, as Google search still king, but Cloud and YouTube strong supporting cast  </p><p>   ** Consumer Discretionary    up 6%. Amazon.com</p><p>  founder Bezos to give reins to cloud boss Jassy as sales rocket past $100 bln  </p><p>   ** Tech    lifts 4.9%. <a href=\"https://laohu8.com/S/PYPL\">PayPal</a>    leaps 15% on upbeat Q4 results as pandemic-driven shift to online shopping sends payment volumes surging  . But Qualcomm</p><p>  falls after sales miss on chip supply constraints</p><p>   ** Meanwhile, the GameStop    roller coaster continues</p><p>  , and when it comes to Super Bowl LV, will the market score, or fumble?   </p><p>   ** SPX performance YTD:    </p><p>(Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)</p><p>((lance.tupper.tr.com@reuters.net lance.tupper@tr.com terence.gabriel.tr.com@reuters.net terence.gabriel@tr.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站",".SPX":"S&P 500 Index","DDG":"ProShares做空石油与天然气ETF","SQQQ":"纳指三倍做空ETF","QLD":"纳指两倍做多ETF","QCOM":"高通","DXD":"道指两倍做空ETF","QNETCN":"纳斯达克中美互联网老虎指数","UCO":"二倍做多彭博原油ETF","PSQ":"纳指反向ETF","CVX":"雪佛龙","DUG":"二倍做空石油与天然气ETF(ProShares)","SDOW":"道指三倍做空ETF-ProShares","09086":"华夏纳指-U","XOM":"埃克森美孚","DWT":"三倍做空原油ETN","DDM":"道指两倍做多ETF","DJX":"1/100道琼斯","TQQQ":"纳指三倍做多ETF","SCO":"二倍做空彭博原油指数ETF","PYPL":"PayPal","QQQ":"纳指100ETF","03086":"华夏纳指","DOG":"道指反向ETF","AMZN":"亚马逊","UDOW":"道指三倍做多ETF-ProShares","QID":"纳指两倍做空ETF",".DJI":"道琼斯","USO":"美国原油ETF","GOOGL":"谷歌A",".IXIC":"NASDAQ Composite"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2109777511","content_text":"** S&P 500    jumps 4.6%, enjoys best week since U.S. elections as investors bet on more government aid to bolster economy      ** That said, the SPX may have tired legs     ** This as the Dow    faces a rough ceiling     ** Indeed, it was 5000 points, and a cloud of dust, though the Nasdaq    may have a crack under the surface     ** But by Fri, the Dow was swinging for its highs   ** Every sector hits paydirt: energy and communication services are the MVPs   ** Energy    surges 8.3%. Oil cos rise as crude hits 1-yr high on growth hopes, OPEC+ supply cuts  . Exxon  gains as Wall Street sees co moving in right direction, and reportedly had discussed merger with Chevron  in early 2020     ** Communication services    rally 7.3%. Alphabet  best in sector, up 14%, as Google search still king, but Cloud and YouTube strong supporting cast     ** Consumer Discretionary    up 6%. Amazon.com  founder Bezos to give reins to cloud boss Jassy as sales rocket past $100 bln     ** Tech    lifts 4.9%. PayPal    leaps 15% on upbeat Q4 results as pandemic-driven shift to online shopping sends payment volumes surging  . But Qualcomm  falls after sales miss on chip supply constraints   ** Meanwhile, the GameStop    roller coaster continues  , and when it comes to Super Bowl LV, will the market score, or fumble?      ** SPX performance YTD:    (Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)((lance.tupper.tr.com@reuters.net lance.tupper@tr.com terence.gabriel.tr.com@reuters.net terence.gabriel@tr.com))","news_type":1},"isVote":1,"tweetType":1,"viewCount":877,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":317022073,"gmtCreate":1612400045493,"gmtModify":1703761297055,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/317022073","repostId":"2108579668","repostType":2,"repost":{"id":"2108579668","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612396458,"share":"https://www.laohu8.com/m/news/2108579668?lang=&edition=full","pubTime":"2021-02-04 07:54","market":"us","language":"en","title":"UPDATE 1-Social network Parler terminates CEO John Matze","url":"https://stock-news.laohu8.com/highlight/detail?id=2108579668","media":"Reuters","summary":"(Adds quote and context)   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conserva","content":"<html><body><p>(Adds quote and context)</p><p>   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conservatives, has dismissed CEO John Matze, according to Matze on Wednesday, as the site has largely gone  offline after the Jan. 6 attack on the U.S. Capitol. </p><p>   Matze confirmed the move in a text message to Reuters.</p><p>   \"On January 29, 2021, the Parler board controlled by Rebekah Mercer decided to immediately terminate my position as CEO of Parler. I did not participate in this decision,\" Matze said in a memo sent to Parler staff, originally reported by Fox News.</p><p>   The company did not immediately respond to a request for comment.</p><p>   Parler remains largely offline after being dropped by Seattle-based Amazon's    cloud-hosting division and the app stores of Apple Inc    and Alphabet Inc's    Google following the Jan. 6 siege of the U.S. Capitol.</p><p>   Parler, which was founded in 2018, has styled itself as a \"free speech-driven\" space. The app has largely attracted U.S. conservatives who disagree with rules around content on social media sites like <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc     and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc   .</p><p> (Reporting by Kanishka Singh in Bengaluru, Elizabeth Culliford in New York and Katie Paul in Palo Alto Editing by Chris Reese and Cynthia Osterman)</p><p>((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-Social network Parler terminates CEO John Matze</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-Social network Parler terminates CEO John Matze\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-04 07:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds quote and context)</p><p>   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conservatives, has dismissed CEO John Matze, according to Matze on Wednesday, as the site has largely gone  offline after the Jan. 6 attack on the U.S. Capitol. </p><p>   Matze confirmed the move in a text message to Reuters.</p><p>   \"On January 29, 2021, the Parler board controlled by Rebekah Mercer decided to immediately terminate my position as CEO of Parler. I did not participate in this decision,\" Matze said in a memo sent to Parler staff, originally reported by Fox News.</p><p>   The company did not immediately respond to a request for comment.</p><p>   Parler remains largely offline after being dropped by Seattle-based Amazon's    cloud-hosting division and the app stores of Apple Inc    and Alphabet Inc's    Google following the Jan. 6 siege of the U.S. Capitol.</p><p>   Parler, which was founded in 2018, has styled itself as a \"free speech-driven\" space. The app has largely attracted U.S. conservatives who disagree with rules around content on social media sites like <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc     and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc   .</p><p> (Reporting by Kanishka Singh in Bengaluru, Elizabeth Culliford in New York and Katie Paul in Palo Alto Editing by Chris Reese and Cynthia Osterman)</p><p>((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","09086":"华夏纳指-U"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108579668","content_text":"(Adds quote and context)   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conservatives, has dismissed CEO John Matze, according to Matze on Wednesday, as the site has largely gone  offline after the Jan. 6 attack on the U.S. Capitol.    Matze confirmed the move in a text message to Reuters.   \"On January 29, 2021, the Parler board controlled by Rebekah Mercer decided to immediately terminate my position as CEO of Parler. I did not participate in this decision,\" Matze said in a memo sent to Parler staff, originally reported by Fox News.   The company did not immediately respond to a request for comment.   Parler remains largely offline after being dropped by Seattle-based Amazon's    cloud-hosting division and the app stores of Apple Inc    and Alphabet Inc's    Google following the Jan. 6 siege of the U.S. Capitol.   Parler, which was founded in 2018, has styled itself as a \"free speech-driven\" space. The app has largely attracted U.S. conservatives who disagree with rules around content on social media sites like Facebook Inc     and Twitter Inc   . (Reporting by Kanishka Singh in Bengaluru, Elizabeth Culliford in New York and Katie Paul in Palo Alto Editing by Chris Reese and Cynthia Osterman)((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314102811,"gmtCreate":1612316052533,"gmtModify":1703760253591,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/314102811","repostId":"2108275853","repostType":2,"repost":{"id":"2108275853","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612313204,"share":"https://www.laohu8.com/m/news/2108275853?lang=&edition=full","pubTime":"2021-02-03 08:46","market":"us","language":"en","title":"PRESS DIGEST- Financial Times - Feb. 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2108275853","media":"Reuters","summary":"Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified","content":"<html><body><p>Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>   Headlines</p><p>   UK starts process to form post-Brexit state-aid watchdog </p><p>   Amazon's Jeff Bezos to step aside as chief executive this year </p><p>   Oxford/AstraZeneca study supports UK decision to delay second doses </p><p>   Steve Cohen's Point72 raises $1.5bn </p><p>   Overview</p><p>   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.</p><p>   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.</p><p>   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.</p><p>    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze.</p><p> (Compiled by Bengaluru newsroom)</p><p>((globalnewsmonitoring@thomsonreuters.com))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PRESS DIGEST- Financial Times - Feb. 3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPRESS DIGEST- Financial Times - Feb. 3\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-03 08:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>   Headlines</p><p>   UK starts process to form post-Brexit state-aid watchdog </p><p>   Amazon's Jeff Bezos to step aside as chief executive this year </p><p>   Oxford/AstraZeneca study supports UK decision to delay second doses </p><p>   Steve Cohen's Point72 raises $1.5bn </p><p>   Overview</p><p>   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.</p><p>   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.</p><p>   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.</p><p>    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze.</p><p> (Compiled by Bengaluru newsroom)</p><p>((globalnewsmonitoring@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊","QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","09086":"华夏纳指-U"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108275853","content_text":"Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.   Headlines   UK starts process to form post-Brexit state-aid watchdog    Amazon's Jeff Bezos to step aside as chief executive this year    Oxford/AstraZeneca study supports UK decision to delay second doses    Steve Cohen's Point72 raises $1.5bn    Overview   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze. (Compiled by Bengaluru newsroom)((globalnewsmonitoring@thomsonreuters.com))","news_type":1},"isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314106459,"gmtCreate":1612316032171,"gmtModify":1703760252561,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"赞！","listText":"赞！","text":"赞！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/314106459","repostId":"2108758903","repostType":2,"repost":{"id":"2108758903","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612314061,"share":"https://www.laohu8.com/m/news/2108758903?lang=&edition=full","pubTime":"2021-02-03 09:01","market":"us","language":"en","title":"New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2108758903","media":"Reuters","summary":"WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the","content":"<html><body><p>WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc</p><p>  and German's BioNTech   , the government said on Wednesday.</p><p>   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.” </p><p>   The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year. </p><p> (Reporting by Praveen Menon; editing by Jane Wardell)</p><p>((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>: ))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Zealand regulator approves Pfizer-BioNTech COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-03 09:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc</p><p>  and German's BioNTech   , the government said on Wednesday.</p><p>   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.” </p><p>   The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year. </p><p> (Reporting by Praveen Menon; editing by Jane Wardell)</p><p>((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>: ))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108758903","content_text":"WELLINGTON, Feb 3 (Reuters) - New Zealand medicines regulator Medsafe has provisionally approved the use of a COVID-19 vaccine jointly developed by U.S. drugmaker Pfizer Inc  and German's BioNTech   , the government said on Wednesday.   \"The provisional approval of the Pfizer-BioNTech vaccine is a positive step in New Zealand’s fight against COVID-19,\" Prime Minister Jacinda Ardern said in a statement. \"It means we can now begin preparations for the first stage in our vaccination roll-out.”    The vaccines are expected to arrive in New Zealand by the end of the first quarter, the government said, adding people at highest risk would be vaccinated first before the broader community from the second half of the year.  (Reporting by Praveen Menon; editing by Jane Wardell)((praveen.menon@thomsonreuters.com; +6448028163; Reuters Messaging: praveen.menon.thomsonreuters.com@reuters.net; Twitter: ))","news_type":1},"isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":382379432,"gmtCreate":1613373033226,"gmtModify":1634553820733,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/382379432","repostId":"2111005930","repostType":2,"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":389370214,"gmtCreate":1612702161938,"gmtModify":1703764372282,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/389370214","repostId":"2109704729","repostType":2,"isVote":1,"tweetType":1,"viewCount":400,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386076310,"gmtCreate":1613121496330,"gmtModify":1634554454632,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"好","listText":"好","text":"好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/386076310","repostId":"2110020257","repostType":2,"repost":{"id":"2110020257","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613120155,"share":"https://www.laohu8.com/m/news/2110020257?lang=&edition=full","pubTime":"2021-02-12 16:55","market":"fut","language":"en","title":"FOREX-Bitcoin clings to Tesla gains, dollar set for weekly loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2110020257","media":"Reuters","summary":"* Bitcoin set for 20% weekly rise   * Traders reassess pace of U.S. recovery on weak jobs data   * E","content":"<html><body><p>* Bitcoin set for 20% weekly rise</p><p>   * Traders reassess pace of U.S. recovery on weak jobs data</p><p>   * Euro ticks down </p><p>   * Graphic: World FX rates </p><p>    By Julien Ponthus</p><p>   LONDON, Feb 12 (Reuters) - Bitcoin    hovered close to record highs on Friday, set for gains of over 20% in a milestone week marked by the endorsement of major firms, such as Elon Musk's Tesla, while the weak U.S. jobs market continued to weigh on the dollar. </p><p>   The world's most popular cryptocurrency last traded 1.1% down at $47,451, just south of a record high of $49,000 reached after U.S. banking group BNY Mellon    said it had formed a unit to help clients hold, transfer, and issue digital assets.</p><p>  Tesla    revealed it had bought $1.5 billion worth of the cryptocurrency and BlackRock   , the world's largest asset manager, added bitcoin as an eligible investment to two funds.  </p><p>   Credit card giant Mastercard's    plans to offer support for some cryptocurrencies also boosted bitcoin's ambitions towards mainstream finance, but many banks are reluctant to engage with it. </p><p>   \"We do not cover other speculative objects such as vintage cars, works of art or expensive watches\", Commerzbank Research said in a note on why it would not comment on the bitcoin exchange rate that some analysts say could test the $50,000 level soon.</p><p>   Elsewhere the dollar headed for its first losing week in three as signs of weakness in the U.S. jobs market dented investor expectations about the pace of economic recovery from the pandemic. </p><p>   In early European trade, the dollar index    edged up 0.15% to 90.55 after subdued volumes in Asia due to the Lunar New Year. It was on track to fall 0.5% for the week.</p><p>   The dollar was slightly up against the yen at 104.940</p><p> . </p><p>   The weaker-than-expected weekly U.S. jobless claims data on Thursday added to concerns the dollar's previous rally had priced in too fast a rebound for the U.S. economy.</p><p>   There has been a divergence in views among traders this year over how U.S. President Joe Biden's planned $1.9 trillion fiscal stimulus package will affect the dollar.</p><p>   Some see it as bolstering the currency as it should speed a U.S. recovery relative to other countries, while others reckoned it would feed a global reflation narrative that should lift riskier assets at the dollar's expense.</p><p>   The euro    slipped 0.17% to $1.2115, consolidating for a third day near that level as it headed for a 0.5% weekly advance.</p><p>   The common currency was flat against the pound at 0.876   after official figures showed Britain's coronavirus-ravaged economy slumped by 9.9% in 2020, the biggest annual crash in more than 300 years, but avoided heading back towards recession at the end of last year.   </p><p>   Norway's crown strengthened slightly and pared some losses against the euro after data showed the country's economy contracted by 2.5% last year, a decline less severe than in most other European nations.</p><p>   It traded last at 10.2940, down 0.1% against the euro.</p><p>    ========================================================</p><p>   Currency bid prices at 8:31AM (831 GMT)</p><p>Description      RIC         Last           U.S. Close  Pct Change     YTD Pct     High Bid    Low Bid</p><p>                                             Previous                   Change                 </p><p>                                             Session                                           </p><p>Euro/Dollar           $1.2109        $1.2133     -0.19%         -0.89%      +1.2135     +1.2105</p><p>Dollar/Yen             104.9600       104.7300    +0.23%         +1.63%      +104.9800   +104.7850</p><p>Euro/Yen              127.09         127.05      +0.03%         +0.13%      +127.2300   +127.0200</p><p>Dollar/Swiss          0.8911         0.8898      +0.16%         +0.73%      +0.8913     +0.8901</p><p>Sterling/Dollar        1.3790         1.3816      -0.17%         +0.96%      +1.3816     +1.3785</p><p>Dollar/Canadian        1.2739         1.2703      +0.28%         +0.04%      +1.2740     +1.2695</p><p>Aussie/Dollar          0.7734         0.7755      -0.25%         +0.55%      +0.7756     +0.7734</p><p>NZ                     0.7200         0.7227      -0.33%         +0.31%      +0.7232     +0.7203</p><p>Dollar/Dollar                                                                                  </p><p>    All spots    Tokyo spots    Europe spots     Volatilities     Tokyo Forex market info from BOJ   </p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ World FX rates    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Julien Ponthus; Editing by Sam Holmes, Simon Cameron-Moore and Barbara lewis)</p><p>((Kevin.Buckland@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FOREX-Bitcoin clings to Tesla gains, dollar set for weekly loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFOREX-Bitcoin clings to Tesla gains, dollar set for weekly loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-12 16:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>* Bitcoin set for 20% weekly rise</p><p>   * Traders reassess pace of U.S. recovery on weak jobs data</p><p>   * Euro ticks down </p><p>   * Graphic: World FX rates </p><p>    By Julien Ponthus</p><p>   LONDON, Feb 12 (Reuters) - Bitcoin    hovered close to record highs on Friday, set for gains of over 20% in a milestone week marked by the endorsement of major firms, such as Elon Musk's Tesla, while the weak U.S. jobs market continued to weigh on the dollar. </p><p>   The world's most popular cryptocurrency last traded 1.1% down at $47,451, just south of a record high of $49,000 reached after U.S. banking group BNY Mellon    said it had formed a unit to help clients hold, transfer, and issue digital assets.</p><p>  Tesla    revealed it had bought $1.5 billion worth of the cryptocurrency and BlackRock   , the world's largest asset manager, added bitcoin as an eligible investment to two funds.  </p><p>   Credit card giant Mastercard's    plans to offer support for some cryptocurrencies also boosted bitcoin's ambitions towards mainstream finance, but many banks are reluctant to engage with it. </p><p>   \"We do not cover other speculative objects such as vintage cars, works of art or expensive watches\", Commerzbank Research said in a note on why it would not comment on the bitcoin exchange rate that some analysts say could test the $50,000 level soon.</p><p>   Elsewhere the dollar headed for its first losing week in three as signs of weakness in the U.S. jobs market dented investor expectations about the pace of economic recovery from the pandemic. </p><p>   In early European trade, the dollar index    edged up 0.15% to 90.55 after subdued volumes in Asia due to the Lunar New Year. It was on track to fall 0.5% for the week.</p><p>   The dollar was slightly up against the yen at 104.940</p><p> . </p><p>   The weaker-than-expected weekly U.S. jobless claims data on Thursday added to concerns the dollar's previous rally had priced in too fast a rebound for the U.S. economy.</p><p>   There has been a divergence in views among traders this year over how U.S. President Joe Biden's planned $1.9 trillion fiscal stimulus package will affect the dollar.</p><p>   Some see it as bolstering the currency as it should speed a U.S. recovery relative to other countries, while others reckoned it would feed a global reflation narrative that should lift riskier assets at the dollar's expense.</p><p>   The euro    slipped 0.17% to $1.2115, consolidating for a third day near that level as it headed for a 0.5% weekly advance.</p><p>   The common currency was flat against the pound at 0.876   after official figures showed Britain's coronavirus-ravaged economy slumped by 9.9% in 2020, the biggest annual crash in more than 300 years, but avoided heading back towards recession at the end of last year.   </p><p>   Norway's crown strengthened slightly and pared some losses against the euro after data showed the country's economy contracted by 2.5% last year, a decline less severe than in most other European nations.</p><p>   It traded last at 10.2940, down 0.1% against the euro.</p><p>    ========================================================</p><p>   Currency bid prices at 8:31AM (831 GMT)</p><p>Description      RIC         Last           U.S. Close  Pct Change     YTD Pct     High Bid    Low Bid</p><p>                                             Previous                   Change                 </p><p>                                             Session                                           </p><p>Euro/Dollar           $1.2109        $1.2133     -0.19%         -0.89%      +1.2135     +1.2105</p><p>Dollar/Yen             104.9600       104.7300    +0.23%         +1.63%      +104.9800   +104.7850</p><p>Euro/Yen              127.09         127.05      +0.03%         +0.13%      +127.2300   +127.0200</p><p>Dollar/Swiss          0.8911         0.8898      +0.16%         +0.73%      +0.8913     +0.8901</p><p>Sterling/Dollar        1.3790         1.3816      -0.17%         +0.96%      +1.3816     +1.3785</p><p>Dollar/Canadian        1.2739         1.2703      +0.28%         +0.04%      +1.2740     +1.2695</p><p>Aussie/Dollar          0.7734         0.7755      -0.25%         +0.55%      +0.7756     +0.7734</p><p>NZ                     0.7200         0.7227      -0.33%         +0.31%      +0.7232     +0.7203</p><p>Dollar/Dollar                                                                                  </p><p>    All spots    Tokyo spots    Europe spots     Volatilities     Tokyo Forex market info from BOJ   </p><p>    &lt;^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ World FX rates    </p><p>   ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^&gt;</p><p>(Reporting by Julien Ponthus; Editing by Sam Holmes, Simon Cameron-Moore and Barbara lewis)</p><p>((Kevin.Buckland@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2110020257","content_text":"* Bitcoin set for 20% weekly rise   * Traders reassess pace of U.S. recovery on weak jobs data   * Euro ticks down    * Graphic: World FX rates     By Julien Ponthus   LONDON, Feb 12 (Reuters) - Bitcoin    hovered close to record highs on Friday, set for gains of over 20% in a milestone week marked by the endorsement of major firms, such as Elon Musk's Tesla, while the weak U.S. jobs market continued to weigh on the dollar.    The world's most popular cryptocurrency last traded 1.1% down at $47,451, just south of a record high of $49,000 reached after U.S. banking group BNY Mellon    said it had formed a unit to help clients hold, transfer, and issue digital assets.  Tesla    revealed it had bought $1.5 billion worth of the cryptocurrency and BlackRock   , the world's largest asset manager, added bitcoin as an eligible investment to two funds.     Credit card giant Mastercard's    plans to offer support for some cryptocurrencies also boosted bitcoin's ambitions towards mainstream finance, but many banks are reluctant to engage with it.    \"We do not cover other speculative objects such as vintage cars, works of art or expensive watches\", Commerzbank Research said in a note on why it would not comment on the bitcoin exchange rate that some analysts say could test the $50,000 level soon.   Elsewhere the dollar headed for its first losing week in three as signs of weakness in the U.S. jobs market dented investor expectations about the pace of economic recovery from the pandemic.    In early European trade, the dollar index    edged up 0.15% to 90.55 after subdued volumes in Asia due to the Lunar New Year. It was on track to fall 0.5% for the week.   The dollar was slightly up against the yen at 104.940 .    The weaker-than-expected weekly U.S. jobless claims data on Thursday added to concerns the dollar's previous rally had priced in too fast a rebound for the U.S. economy.   There has been a divergence in views among traders this year over how U.S. President Joe Biden's planned $1.9 trillion fiscal stimulus package will affect the dollar.   Some see it as bolstering the currency as it should speed a U.S. recovery relative to other countries, while others reckoned it would feed a global reflation narrative that should lift riskier assets at the dollar's expense.   The euro    slipped 0.17% to $1.2115, consolidating for a third day near that level as it headed for a 0.5% weekly advance.   The common currency was flat against the pound at 0.876   after official figures showed Britain's coronavirus-ravaged economy slumped by 9.9% in 2020, the biggest annual crash in more than 300 years, but avoided heading back towards recession at the end of last year.      Norway's crown strengthened slightly and pared some losses against the euro after data showed the country's economy contracted by 2.5% last year, a decline less severe than in most other European nations.   It traded last at 10.2940, down 0.1% against the euro.    ========================================================   Currency bid prices at 8:31AM (831 GMT)Description      RIC         Last           U.S. Close  Pct Change     YTD Pct     High Bid    Low Bid                                             Previous                   Change                                                              Session                                           Euro/Dollar           $1.2109        $1.2133     -0.19%         -0.89%      +1.2135     +1.2105Dollar/Yen             104.9600       104.7300    +0.23%         +1.63%      +104.9800   +104.7850Euro/Yen              127.09         127.05      +0.03%         +0.13%      +127.2300   +127.0200Dollar/Swiss          0.8911         0.8898      +0.16%         +0.73%      +0.8913     +0.8901Sterling/Dollar        1.3790         1.3816      -0.17%         +0.96%      +1.3816     +1.3785Dollar/Canadian        1.2739         1.2703      +0.28%         +0.04%      +1.2740     +1.2695Aussie/Dollar          0.7734         0.7755      -0.25%         +0.55%      +0.7756     +0.7734NZ                     0.7200         0.7227      -0.33%         +0.31%      +0.7232     +0.7203Dollar/Dollar                                                                                      All spots    Tokyo spots    Europe spots     Volatilities     Tokyo Forex market info from BOJ       <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ World FX rates       ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>(Reporting by Julien Ponthus; Editing by Sam Holmes, Simon Cameron-Moore and Barbara lewis)((Kevin.Buckland@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":806,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":380841348,"gmtCreate":1612535373684,"gmtModify":1703763268768,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/380841348","repostId":"2109762467","repostType":2,"repost":{"id":"2109762467","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612534346,"share":"https://www.laohu8.com/m/news/2109762467?lang=&edition=full","pubTime":"2021-02-05 22:12","market":"sh","language":"en","title":"Too delicate: Germany ducks Taiwan appeal for COVID-19 vaccine supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2109762467","media":"Reuters","summary":"By Michael Nienaber   BERLIN, Feb 5 (Reuters) - Germany on Friday ducked an appeal by Taiwan for its","content":"<html><body><p>By Michael Nienaber</p><p>   BERLIN, Feb 5 (Reuters) - Germany on Friday ducked an appeal by Taiwan for its help to supply COVID-19 vaccines, as the Asian tech powerhouse's request for assistance following Berlin's plea to ease a semiconductor supply crunch in the auto industry risked provoking China's ire.</p><p>   In an exchange between the economy ministers of Germany and Taiwan last month, Berlin first asked Taipei to persuade its chip foundries to increase supply to German car makers that have had to rein in production due to chip shortages.</p><p>   While promising help on chips, Taiwan Economy Minister Wang Mei-hua appealed to Germany's de facto ambassador in Taipei for assistance in obtaining vaccines, none of which has arrived on the island yet.  </p><p>   The exchange risks angering Beijing, which considers self-ruled Taiwan a wayward province. Though German industry relies on chips made by the likes of Taiwan Semiconductor Manufacturing Corp   , China is its largest trading partner and a big export market for its cars.</p><p>   Asked at a regular news conference whether the Germany would entertain the idea of some kind of chips-for-vaccines deal, spokesmen for both the economy and foreign ministries declined comment.</p><p>   A person familiar with discussions between the two governments said the diplomatic implications of any such agreement were tricky, as were the optics of exporting vaccines that remain in short supply at home.</p><p>   The first COVID-19 vaccine to win European approval was devised by German biotech startup BioNTech   , which is marketing the shot in partnership with U.S. drug company Pfizer Inc   . </p><p>   BioNTech, meanwhile, has an existing arrangement to market 100 million doses of its vaccine in China through Fosun Pharma. A company spokeswoman said initial talks were under way with Fosun on expanding that cooperation.   </p><p>   \"We may consider shipping the bulk vaccine substance to mainland China and packaging there, or even producing the vaccine in mainland China through our partner Fosun Pharma, but these ideas are all under discussion,\" the spokeswoman said.</p><p>   Asked whether it might supply vaccine to Taiwan, BioNTech declined to comment \"on potential or planned specifics of our commercial discussions\".</p><p>   China has vowed to bring Taiwan under its rule and has not renounced the use of force to do so.</p><p> (Additional reporting and writing by Douglas Busvine; Additional reporting by Andreas Rinke; Editing by Ben Blanchard and Nick Macfie)</p><p>((douglas.busvine@tr.com; +49 30 220 133 562;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Too delicate: Germany ducks Taiwan appeal for COVID-19 vaccine supply</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToo delicate: Germany ducks Taiwan appeal for COVID-19 vaccine supply\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-05 22:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>By Michael Nienaber</p><p>   BERLIN, Feb 5 (Reuters) - Germany on Friday ducked an appeal by Taiwan for its help to supply COVID-19 vaccines, as the Asian tech powerhouse's request for assistance following Berlin's plea to ease a semiconductor supply crunch in the auto industry risked provoking China's ire.</p><p>   In an exchange between the economy ministers of Germany and Taiwan last month, Berlin first asked Taipei to persuade its chip foundries to increase supply to German car makers that have had to rein in production due to chip shortages.</p><p>   While promising help on chips, Taiwan Economy Minister Wang Mei-hua appealed to Germany's de facto ambassador in Taipei for assistance in obtaining vaccines, none of which has arrived on the island yet.  </p><p>   The exchange risks angering Beijing, which considers self-ruled Taiwan a wayward province. Though German industry relies on chips made by the likes of Taiwan Semiconductor Manufacturing Corp   , China is its largest trading partner and a big export market for its cars.</p><p>   Asked at a regular news conference whether the Germany would entertain the idea of some kind of chips-for-vaccines deal, spokesmen for both the economy and foreign ministries declined comment.</p><p>   A person familiar with discussions between the two governments said the diplomatic implications of any such agreement were tricky, as were the optics of exporting vaccines that remain in short supply at home.</p><p>   The first COVID-19 vaccine to win European approval was devised by German biotech startup BioNTech   , which is marketing the shot in partnership with U.S. drug company Pfizer Inc   . </p><p>   BioNTech, meanwhile, has an existing arrangement to market 100 million doses of its vaccine in China through Fosun Pharma. A company spokeswoman said initial talks were under way with Fosun on expanding that cooperation.   </p><p>   \"We may consider shipping the bulk vaccine substance to mainland China and packaging there, or even producing the vaccine in mainland China through our partner Fosun Pharma, but these ideas are all under discussion,\" the spokeswoman said.</p><p>   Asked whether it might supply vaccine to Taiwan, BioNTech declined to comment \"on potential or planned specifics of our commercial discussions\".</p><p>   China has vowed to bring Taiwan under its rule and has not renounced the use of force to do so.</p><p> (Additional reporting and writing by Douglas Busvine; Additional reporting by Andreas Rinke; Editing by Ben Blanchard and Nick Macfie)</p><p>((douglas.busvine@tr.com; +49 30 220 133 562;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2109762467","content_text":"By Michael Nienaber   BERLIN, Feb 5 (Reuters) - Germany on Friday ducked an appeal by Taiwan for its help to supply COVID-19 vaccines, as the Asian tech powerhouse's request for assistance following Berlin's plea to ease a semiconductor supply crunch in the auto industry risked provoking China's ire.   In an exchange between the economy ministers of Germany and Taiwan last month, Berlin first asked Taipei to persuade its chip foundries to increase supply to German car makers that have had to rein in production due to chip shortages.   While promising help on chips, Taiwan Economy Minister Wang Mei-hua appealed to Germany's de facto ambassador in Taipei for assistance in obtaining vaccines, none of which has arrived on the island yet.     The exchange risks angering Beijing, which considers self-ruled Taiwan a wayward province. Though German industry relies on chips made by the likes of Taiwan Semiconductor Manufacturing Corp   , China is its largest trading partner and a big export market for its cars.   Asked at a regular news conference whether the Germany would entertain the idea of some kind of chips-for-vaccines deal, spokesmen for both the economy and foreign ministries declined comment.   A person familiar with discussions between the two governments said the diplomatic implications of any such agreement were tricky, as were the optics of exporting vaccines that remain in short supply at home.   The first COVID-19 vaccine to win European approval was devised by German biotech startup BioNTech   , which is marketing the shot in partnership with U.S. drug company Pfizer Inc   .    BioNTech, meanwhile, has an existing arrangement to market 100 million doses of its vaccine in China through Fosun Pharma. A company spokeswoman said initial talks were under way with Fosun on expanding that cooperation.      \"We may consider shipping the bulk vaccine substance to mainland China and packaging there, or even producing the vaccine in mainland China through our partner Fosun Pharma, but these ideas are all under discussion,\" the spokeswoman said.   Asked whether it might supply vaccine to Taiwan, BioNTech declined to comment \"on potential or planned specifics of our commercial discussions\".   China has vowed to bring Taiwan under its rule and has not renounced the use of force to do so. (Additional reporting and writing by Douglas Busvine; Additional reporting by Andreas Rinke; Editing by Ben Blanchard and Nick Macfie)((douglas.busvine@tr.com; +49 30 220 133 562;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":317026310,"gmtCreate":1612400012630,"gmtModify":1703761295878,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/317026310","repostId":"2108796672","repostType":2,"repost":{"id":"2108796672","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612396860,"share":"https://www.laohu8.com/m/news/2108796672?lang=&edition=full","pubTime":"2021-02-04 08:01","market":"us","language":"en","title":"Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2108796672","media":"Reuters","summary":"LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses genera","content":"<html><body><p>LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></p><p>  are combined in a two-shot schedule.    </p><p>   The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.    </p><p>   The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks. </p><p>   Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine. </p><p>   It is expected more vaccines will be added to the trial when they are approved and rolled out.</p><p>   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.</p><p>   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.</p><p>   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.</p><p>   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.</p><p>   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.</p><p>   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.  </p><p> (Reporting by Alistair Smout Editing by Bill Berkrot)</p><p>((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBritain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-04 08:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></p><p>  are combined in a two-shot schedule.    </p><p>   The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.    </p><p>   The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks. </p><p>   Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine. </p><p>   It is expected more vaccines will be added to the trial when they are approved and rolled out.</p><p>   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.</p><p>   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.</p><p>   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.</p><p>   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.</p><p>   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.</p><p>   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.  </p><p> (Reporting by Alistair Smout Editing by Bill Berkrot)</p><p>((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108796672","content_text":"LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and AstraZeneca Plc  are combined in a two-shot schedule.       The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.       The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks.    Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine.    It is expected more vaccines will be added to the trial when they are approved and rolled out.   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.   (Reporting by Alistair Smout Editing by Bill Berkrot)((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}